Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036428	pf-ada	U/l (u/l)	2779	3494	0.14%
3036428	pf-ada	— (—)	307	347	100.00%	Distribution not available
3036428	pf-ada	U/l_______ (u/l)	41	54	0.00%
3036428	pf-ada	__________ (—)	16	18	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm of bronchus and lung

468

492

8.31

320.73

1.2

1.3

12.25

11.67

u/l

0.25

458

446

Non-small cell lung cancer, including Hilmo

400

431

9.14

311.27

1.2

1.3

11.50

11.30

u/l

0.08

389

387

Abnormal findings on diagnostic imaging of lung

791

1712

4.48

309.80

1.3

14.06

14.08

u/l

0.00

742

1579

All pneumoniae

1191

1336

5.88

307.65

1.3

15.61

13.74

u/l

0.66

1079

1250

1037

1089

5.65

307.65

1.3

15.00

13.64

u/l

0.40

951

1019

Heart failure,strict

833

1027

5.80

307.65

1.4

1.2

11.33

15.58

u/l

4.16

732

985

Heart failure, strict

918

1399

4.67

307.65

1.3

1.2

11.05

15.99

u/l

3.30

802

1331

Malignant neoplasm of bronchus and lung, including Hilmo

535

547

8.53

307.65

1.2

1.3

12.39

11.74

u/l

0.32

520

495

Asthma, excluding more controls

374

31.18

307.65

1.2

1.1

13.74

10.08

u/l

1.32

336

Any death

904

1218

5.31

307.65

1.3

13.81

13.95

u/l

0.03

829

1128

Excluding asthma or asthma-COPD overlap

565

141

20.27

307.65

1.3

1.1

12.83

8.64

u/l

1.68

524

115

COPD differential diagnosis

563

141

20.20

307.65

1.3

1.1

12.83

8.67

u/l

1.67

523

115

Pleural effusion

1762

204

113.85

307.65

1.4

1.1

13.89

13.05

u/l

0.21

1700

168

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

700

588

10.33

307.65

1.3

14.16

11.90

u/l

1.11

682

533

COPD (mode)

397

109

29.06

307.65

1.2

1.1

14.35

8.02

u/l

1.88

361

All-cause Heart Failure

895

1375

4.63

307.65

1.3

1.2

11.18

15.95

u/l

3.01

781

1309

Other medical care

835

1299

5.53

307.65

1.3

14.09

13.85

u/l

0.05

779

1210

Later onset COPD, excluding more controls

297

24.75

307.65

1.3

1.1

14.34

8.55

u/l

1.27

270

Other pleural conditions

895

125

88.62

307.65

1.4

1.1

13.33

14.93

u/l

0.26

849

100

Suppurative and necrotic conditions of lower respiratory tract

371

175

25.04

307.65

1.4

1.3

25.97

12.04

u/l

7.51

349

160

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1037

1089

5.65

307.65

1.3

15.00

13.64

u/l

0.40

951

1019

Asthma, unspecified (mode)

358

137

19.04

307.65

1.3

1.1

14.11

8.69

u/l

1.78

323

113

Pneumonias (Asthma/COPD co-morbidities)

1196

1339

5.92

307.65

1.3

15.59

13.67

u/l

0.69

1085

1252

Influenza and pneumonia

1159

1297

5.59

307.65

1.3

15.53

13.69

u/l

0.63

1058

1216

ILD differential diagnosis

562

141

20.17

307.65

1.3

1.1

12.84

8.67

u/l

1.68

522

115

Asthma, unspecified (mode), excluding more controls

342

40.50

307.65

1.3

1.1

14.29

10.08

u/l

1.51

309

Malignant neoplasm of respiratory system and intrathoracic organs

635

543

10.24

307.65

1.3

14.20

11.78

u/l

1.10

621

490

Other pulmonary diagnosis

578

141

20.75

307.65

1.3

1.1

12.60

8.64

u/l

1.56

536

115

Heart failure, not strict

936

1216

5.27

307.65

1.3

1.2

12.85

15.67

u/l

0.89

834

1163

Pyothorax

339

145

28.73

307.65

1.4

1.3

26.64

11.76

u/l

7.31

320

132

Lung cancer and mesothelioma

659

78.69

307.65

1.3

1.1

13.17

9.08

u/l

0.75

644

Pneumonia, organism unspecified

1144

1290

6.18

307.65

1.3

15.30

13.57

u/l

0.58

1048

1210

Other diseases of pleura

2190

581

35.94

307.65

1.3

1.1

13.66

17.29

u/l

0.63

2076

492

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1200

1358

5.97

307.65

1.3

15.51

13.65

u/l

0.67

1087

1270

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

904

1972

4.06

304.63

1.4

1.2

13.74

13.83

u/l

0.03

843

1810

Asthma (only as main-diagnosis), excluding more controls

322

28.90

302.72

1.3

1.1

13.39

10.08

u/l

1.16

288

Asthma

400

140

14.84

289.39

1.2

1.1

13.65

8.63

u/l

1.70

359

114

Dyspnoea

998

1941

3.76

286.11

1.4

1.2

14.61

13.99

u/l

0.15

919

1791

Bacterial infection, other or unspecified, including avohilmo

792

1555

4.25

277.86

1.3

16.19

12.91

u/l

0.83

727

1447

Other bacterial diseases

971

1754

3.71

265.62

1.3

16.38

13.35

u/l

0.94

880

1634

Bacterial infection, other or unspecified

751

1523

4.24

265.13

1.3

16.17

13.02

u/l

0.73

689

1419

Diseases of the respiratory system

405

166

12.33

264.84

1.3

1.1

11.77

9.23

u/l

1.05

373

142

Asthma (only as main-diagnosis)

349

140

14.02

261.47

1.3

1.1

13.11

8.63

u/l

1.45

314

114

Non-small cell lung cancer

297

307

10.09

254.61

1.2

1.3

11.73

11.34

u/l

0.13

288

274

Early onset COPD, excluding more controls

172

27.28

252.51

1.2

1.1

13.55

9.37

u/l

0.60

159

Asthma (mode)

355

141

13.31

248.63

1.3

1.1

12.26

8.67

u/l

1.28

323

115

Other bacterial diseases, including avohilmo

928

1650

3.54

233.75

1.3

16.93

13.28

u/l

1.17

849

1534

Non-small cell lung cancer, adenocarcinoma

204

158

13.89

215.43

1.2

1.3

12.24

10.87

u/l

0.43

196

137

Oxycodone

582

1160

4.38

214.95

1.3

12.38

13.59

u/l

0.83

542

1061

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

190

135

15.02

210.63

1.5

1.2

15.01

9.90

u/l

5.68

185

115

Heart failure and antihypertensive medication

362

309

7.79

209.91

1.4

1.2

11.31

16.72

u/l

2.23

308

290

Pneumothorax

143

23.77

198.18

1.4

1.1

12.99

14.98

u/l

0.21

134

Bacterial pneumoniae

480

912

4.70

195.80

1.3

15.36

13.87

u/l

0.32

404

863

Bacterial pneumonia, not elsewhere classified

467

879

4.74

192.75

1.3

15.20

13.87

u/l

0.27

392

831

Renal tubulo-interstitial diseases

838

1936

3.20

190.90

1.3

12.73

14.70

u/l

1.04

738

1821

Persons encountering health services for specific procedures and health care

871

1597

3.24

189.09

1.3

1.2

14.66

15.04

u/l

0.07

794

1482

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

902

2007

3.06

185.72

1.3

14.57

14.19

u/l

0.07

821

1861

Non-ischemic cardiomyopathy

478

832

4.67

185.60

1.4

1.2

12.08

14.51

u/l

1.05

424

796

Bacterial Sepsis

640

1478

3.64

182.78

1.3

12.81

14.38

u/l

0.55

560

1388

Renal failure

677

1761

3.33

170.42

1.3

10.49

14.90

u/l

3.86

582

1654

Non-invasive ventilation

276

344

7.04

169.97

1.4

1.2

12.93

16.59

u/l

1.51

213

335

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

288

469

6.31

168.84

1.2

1.3

12.13

11.88

u/l

0.10

277

424

Heart failure and bmi 25plus

462

695

4.52

162.50

1.3

12.66

17.57

u/l

1.19

407

663

Septicaemia

543

1372

3.67

161.49

1.3

13.62

13.00

u/l

0.21

483

1276

Implicit bacterial Sepsis

573

1397

3.58

161.27

1.4

1.3

12.61

14.44

u/l

0.62

497

1311

Implicit bacterial Sepsis, including avohilmo

603

1467

3.47

161.15

1.3

12.54

14.41

u/l

0.68

525

1378

Pleural plaque

162

138

12.19

160.41

1.4

1.1

13.96

15.05

u/l

0.16

152

108

Abnormalities of breathing

715

1242

3.32

159.08

1.3

1.2

15.49

15.13

u/l

0.06

658

1159

Explicit Sepsis, including avohilmo

561

1456

3.55

158.61

1.3

13.69

14.29

u/l

0.16

500

1368

All chronic kidney diseases

639

1566

3.30

155.96

1.3

11.00

14.84

u/l

2.74

555

1475

COPD/asthma related infections

724

1089

3.35

155.69

1.3

13.37

13.64

u/l

0.06

657

1019

COPD/asthma/ILD related infections

724

1089

3.35

155.69

1.3

13.37

13.64

u/l

0.06

657

1019

Implicit Sepsis

731

1779

3.06

154.66

1.3

13.08

14.80

u/l

0.65

644

1670

Explicit Sepsis

550

1444

3.52

154.13

1.3

13.60

14.33

u/l

0.19

490

1358

Non-small cell lung cancer, adenocarcinoma, helper endpoint

204

257

8.51

152.69

1.2

1.3

12.24

14.00

u/l

0.39

196

233

Malignant neoplasm

618

1044

3.49

149.64

1.3

14.12

13.45

u/l

0.18

586

941

Malignant neoplasm

613

1042

3.47

147.10

1.3

14.08

13.43

u/l

0.17

582

940

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

315

613

5.09

145.66

1.2

1.3

11.69

12.01

u/l

0.15

295

558

All kidney diseases

795

1892

2.84

143.98

1.3

12.93

15.22

u/l

1.19

708

1779

Solid cancers

603

1038

3.43

142.37

1.3

14.29

13.46

u/l

0.22

572

937

Other septicaemia, including avohilmo

491

1311

3.57

141.69

1.3

13.36

13.10

u/l

0.08

437

1217

Liquid cancers, including Hilmo

385

802

4.30

141.18

1.3

21.00

12.50

u/l

1.23

354

725

Malignant neoplasm, including Hilmo

607

1047

3.40

141.16

1.3

14.11

13.45

u/l

0.17

574

944

Malignant neoplasm, wide definition

608

1050

3.40

140.99

1.3

14.21

13.46

u/l

0.20

575

947

Valvular heart disease excluding rheumatic fever

456

836

3.94

139.61

1.4

1.2

15.37

16.13

u/l

0.08

413

800

Non-rheumatic valve diseases

455

836

3.93

138.73

1.4

1.2

15.37

16.13

u/l

0.08

412

800

Other septicaemia

480

1290

3.57

138.32

1.3

13.27

13.14

u/l

0.04

427

1199

Solid cancers, including Hilmo

598

1045

3.36

136.56

1.3

14.13

13.44

u/l

0.18

566

942

Any event in cancer register

619

1121

3.25

134.46

1.3

14.02

13.44

u/l

0.15

583

1016

Other heart diseases, wide

584

1068

3.33

133.57

1.3

1.2

13.31

16.37

u/l

1.16

520

1015

Implicit Sepsis, including avohilmo

714

1801

2.86

133.35

1.3

13.03

14.91

u/l

0.72

630

1689

Fever of other and unknown origin

546

1484

3.22

131.82

1.3

15.31

13.69

u/l

0.44

503

1383

Heart failure and coronary heart disease

598

1361

3.13

128.89

1.4

1.3

9.81

14.27

u/l

4.48

514

1278

Liquid cancers

329

717

4.42

127.67

1.3

22.45

12.53

u/l

1.24

304

647

Nephropathy related operations

220

373

6.11

124.23

1.4

1.3

9.43

14.02

u/l

2.43

186

344

Dialysis, with operation codes

223

384

6.01

123.87

1.4

1.3

9.73

14.11

u/l

2.32

188

360

Other heart diseases

274

332

5.40

116.85

1.3

1.2

11.43

18.17

u/l

5.23

239

316

Acute renal failure

338

869

3.98

115.54

1.3

10.78

16.19

u/l

2.05

295

812

Chronic kidney disease

461

1389

3.25

115.40

1.4

1.3

10.08

15.19

u/l

3.46

391

1299

Condition for Implicit Sepsis (Organ dysfunction codes)

690

1785

2.70

115.23

1.3

13.01

14.97

u/l

0.75

611

1675

Any gastric operation

431

568

3.83

111.39

1.3

1.2

12.70

14.09

u/l

0.53

401

521

GASTRO-related operations

431

568

3.83

111.39

1.3

1.2

12.70

14.09

u/l

0.53

401

521

First line medication for Crohn's disease

791

1679

2.55

110.06

1.3

1.2

14.76

14.62

u/l

0.03

732

1535

Erysipelas, including avohilmo

604

1623

2.78

108.68

1.3

13.90

13.17

u/l

0.27

551

1512

Bacterial pneumonia (organism specified)

510

1574

2.97

108.49

1.3

15.57

13.79

u/l

0.57

431

1486

Oral corticosteroids

804

1981

2.39

100.91

1.3

1.2

13.86

14.09

u/l

0.08

734

1825

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

657

1727

2.58

100.43

1.3

12.96

15.29

u/l

0.94

583

1624

Non-allergic asthma (mode)

14.65

97.83

1.3

1.2

12.37

9.32

u/l

0.36

Atrial fibrillation and flutter

230

283

5.30

95.78

1.3

1.2

10.62

17.78

u/l

5.42

204

269

COPD

524

1556

2.77

95.59

1.2

1.3

14.83

13.00

u/l

0.76

482

1441

ILD medications: prednisolone, methylprednisolone, prednisone

776

1841

2.36

92.78

1.3

1.2

13.90

14.27

u/l

0.13

707

1698

Aplastic and other anaemias

530

1839

2.67

92.64

1.3

13.08

14.05

u/l

0.28

473

1708

Atrial fibrillation and flutter with reimbursement

212

248

5.45

89.83

1.3

1.2

11.08

18.13

u/l

4.50

183

235

Secondary uncertain malignant neoplasm

172

316

5.57

89.04

1.3

16.21

11.41

u/l

1.11

162

278

Other chronic obstructive pulmonary disease

501

1526

2.72

88.58

1.3

13.76

13.06

u/l

0.26

459

1414

Care involving dialysis

131

188

7.21

86.98

1.4

1.3

8.20

11.31

u/l

2.53

112

171

ILD medications

776

1844

2.28

85.57

1.3

1.2

14.93

14.33

u/l

0.16

712

1701

Erysipelas

489

1598

2.66

84.22

1.3

13.63

13.21

u/l

0.12

440

1491

Other anaemias

494

1786

2.62

83.70

1.3

12.47

13.99

u/l

0.54

441

1658

Diseases of arteries, arterioles and capillaries (FINNGEN)

190

244

5.43

83.59

1.3

1.2

9.49

17.61

u/l

8.66

168

231

Inflammatory bowel disease treatment related agents

790

1988

2.22

82.24

1.3

1.2

15.01

14.14

u/l

0.27

721

1831

Ascites

142

236

6.24

82.00

1.3

11.42

12.18

u/l

0.16

133

220

Other and unspecified anaemias

488

1780

2.61

81.76

1.3

12.51

14.01

u/l

0.52

435

1652

Cardiomyopathy

194

430

4.59

80.59

1.3

1.2

10.75

16.29

u/l

1.50

174

412

Other chronic obstructive pulmonary disease, including avohilmo

554

1887

2.44

78.49

1.3

13.62

14.21

u/l

0.18

508

1744

Covid-19 confirmed case

404

1466

2.79

78.39

1.3

19.11

12.95

u/l

0.83

369

1347

COPD, early/later onset

508

1718

2.51

77.08

1.3

13.71

14.40

u/l

0.20

466

1595

COPD, hospital admissions

502

1703

2.51

76.34

1.3

13.88

14.31

u/l

0.11

460

1581

ILD medications: immunosuppressive drugs

437

1546

2.58

71.65

1.3

1.2

16.77

14.78

u/l

0.45

403

1424

Cardiac arrhythmias

310

613

3.26

70.43

1.3

1.2

11.61

17.60

u/l

3.29

275

579

COPD related to multimorbidity

459

1561

2.52

70.08

1.3

13.80

14.54

u/l

0.19

419

1448

Non-Hodgkin lymphoma, all, including Hilmo

149

305

4.99

68.35

1.3

25.91

11.59

u/l

1.80

140

270

Codes for special purposes

452

1839

2.46

68.20

1.3

19.14

13.06

u/l

0.95

414

1695

Provisional assignment of new diseases of uncertain etiology

451

1839

2.45

67.75

1.3

19.17

13.06

u/l

0.95

413

1695

Haemorrhage from respiratory passages

328

1010

2.90

67.11

1.3

1.2

11.79

14.09

u/l

1.38

294

948

COPD, hospital admission 2, with asthma infections

393

1299

2.64

66.43

1.2

1.3

13.79

14.67

u/l

0.21

357

1201

Implicit viral Sepsis, including avohilmo

304

1035

2.97

66.35

1.3

12.28

14.98

u/l

0.71

272

968

Other disorders of fluid, electrolyte and acid-base balance

345

1181

2.79

66.15

1.3

11.64

14.55

u/l

0.85

312

1092

Cerebrovascular diseases (FINNGEN)

182

286

4.49

65.81

1.3

1.2

12.02

17.92

u/l

3.14

162

272

Extracorporeal dialysis

109

179

6.33

63.82

1.4

1.3

8.16

12.55

u/l

2.40

164

COPD, hospital admissions 3, with asthma pneumonia sepsis

356

1138

2.72

63.72

1.2

1.3

13.98

14.64

u/l

0.13

322

1051

Infections, IBD-co-morbidities

158

228

4.94

63.37

1.4

1.2

17.72

12.72

u/l

1.72

144

215

Implicit viral Sepsis

228

676

3.42

63.18

1.4

1.3

12.67

15.45

u/l

0.47

207

631

Viral Sepsis

228

676

3.42

63.17

1.4

1.3

12.67

15.45

u/l

0.47

207

631

All influenza

202

554

3.68

62.86

1.4

1.3

14.72

15.12

u/l

0.04

181

524

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

155

359

4.39

61.08

1.3

16.91

11.85

u/l

1.02

143

321

Acute tubulo-interstitial nephritis

474

1737

2.32

60.98

1.3

14.43

14.65

u/l

0.05

425

1637

AV-block

195

444

3.81

60.60

1.3

1.2

11.74

15.76

u/l

1.13

175

424

Asthma-related pneumonia

368

1452

2.55

60.25

1.2

1.3

13.95

14.28

u/l

0.07

325

1338

Asthma, hospital admissions 3, pneumonia

368

1455

2.55

59.98

1.2

1.3

13.95

14.27

u/l

0.07

325

1340

Asthma-related pneumonia or sepsis

368

1455

2.55

59.98

1.2

1.3

13.95

14.27

u/l

0.07

325

1340

Certain infectious and parasitic diseases

563

1254

2.26

59.81

1.3

15.88

13.20

u/l

0.47

516

1182

Conduction disorders

256

652

3.18

59.67

1.4

1.2

11.38

16.04

u/l

2.09

231

627

Pulmonary heart disease, diseases of pulmonary circulation

340

1305

2.64

59.44

1.3

10.69

15.17

u/l

2.82

314

1199

Secondary and unspecified malignant neoplasm of lymph nodes

103

172

6.13

59.09

1.4

1.2

19.67

9.87

u/l

1.61

150

Cardiovascular diseases (excluding rheumatic etc)

225

350

3.69

58.94

1.2

11.68

18.59

u/l

7.12

206

334

Continuous positive airway pressure

156

301

4.37

57.90

1.2

1.3

14.68

18.76

u/l

0.64

146

292

Viral pneumonia

125

256

4.96

57.30

1.4

1.3

10.94

11.77

u/l

0.27

114

245

ILD, hospital admissions 3, with pneumonia sepsis

118

232

5.22

56.88

1.3

15.49

12.19

u/l

0.80

107

219

Allergic asthma (mode)

12.82

56.26

1.3

1.1

10.62

12.11

u/l

0.11

ILD, hospital admission 2, with pulmonary infections

124

257

4.93

56.18

1.3

15.52

11.74

u/l

1.05

112

245

Primary_lymphoid and hematopoietic malignant neoplasms

270

951

2.88

55.89

1.3

24.83

13.17

u/l

1.19

250

867

Tramadol

492

1312

2.27

55.51

1.3

12.34

14.58

u/l

1.49

456

1201

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

622

1929

2.05

55.23

1.3

15.65

14.24

u/l

0.21

557

1802

Hypertensive heart and/or renal disease

281

713

2.92

55.03

1.3

10.31

14.60

u/l

2.86

256

678

Valvular operations

149

365

4.15

54.59

1.4

1.2

12.16

16.59

u/l

0.87

140

346

Cardiomyopathy (excluding other)

136

312

4.44

54.34

1.2

11.72

16.31

u/l

0.68

119

296

Other arrhythmias

342

999

2.57

53.55

1.3

1.2

13.69

16.10

u/l

0.99

311

952

Malignant neoplasm of breast, HER2-negative

194

342

3.68

52.93

1.2

11.13

11.93

u/l

0.26

182

296

Malignant neoplasm of breast

194

342

3.68

52.91

1.2

11.13

11.93

u/l

0.26

182

296

Presence of cardiac and vascular implants and grafts

453

1495

2.25

52.62

1.4

1.3

9.96

13.86

u/l

3.39

395

1400

L04AD Calcineurin inhibitors

109

216

5.14

51.99

1.3

9.26

11.77

u/l

1.74

202

Polyarthropathies

507

1516

2.16

51.93

1.3

15.95

13.41

u/l

0.81

465

1404

Bleeding

614

2180

1.99

51.39

1.3

12.47

14.75

u/l

1.04

552

2028

Malignant neoplasm of breast, HER2-negative, including Hilmo

193

344

3.62

51.26

1.2

11.08

11.91

u/l

0.27

180

297

Malignant neoplasm of breast, including Hilmo

193

344

3.61

51.25

1.2

11.08

11.91

u/l

0.27

180

297

Diseases of arteries, arterioles and capillaries

569

2070

2.03

51.02

1.3

11.25

14.49

u/l

2.14

505

1926

Opioids

545

1330

2.12

50.65

1.2

1.3

12.33

14.83

u/l

1.87

509

1218

Other diseases of the respiratory system

242

854

2.88

50.00

1.4

1.3

13.67

12.99

u/l

0.14

218

779

Other respiratory disorders and diseases

242

854

2.88

50.00

1.4

1.3

13.67

12.99

u/l

0.14

218

779

Glomerular disorders in diseases classified elsewhere

148

387

3.91

49.74

1.4

1.3

11.36

13.51

u/l

0.54

130

357

Cardiomyopathies, Primary/intrinsic

127

297

4.35

49.54

1.2

11.89

16.00

u/l

0.54

112

281

Pulmonary embolism

297

1168

2.57

49.51

1.3

11.11

15.56

u/l

2.33

274

1072

Glomerular diseases

196

618

3.22

49.35

1.3

12.18

12.93

u/l

0.20

170

573

Transplanted organ and tissue status

111

234

4.84

49.30

1.3

7.84

13.08

u/l

4.68

100

216

Pulmonary heart disease

297

1178

2.55

48.65

1.3

11.11

15.27

u/l

2.13

274

1081

Symptoms and signs involving the circulatory and respiratory systems

523

1243

2.12

47.79

1.3

1.2

11.72

15.15

u/l

3.41

479

1160

Hypertensive diseases (excluding secondary)

197

333

3.46

47.51

1.3

1.2

11.90

17.98

u/l

5.20

176

317

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

181

319

3.59

47.46

1.3

1.2

17.36

17.31

u/l

0.00

157

304

Venous thromboembolism

458

2122

2.09

47.13

1.3

12.11

14.08

u/l

1.28

415

1955

DVT of lower extremities and pulmonary embolism

382

1710

2.25

47.07

1.3

11.48

14.41

u/l

1.93

348

1573

Malaise and fatigue

393

1382

2.25

46.77

1.3

14.39

13.43

u/l

0.35

355

1290

Malignant neoplasm of skin

323

880

2.50

46.68

1.2

1.3

13.51

12.69

u/l

0.26

303

795

Neoplasms

329

681

2.54

45.83

1.3

13.45

15.04

u/l

0.66

308

615

Malignant neoplasm of breast, HER-positive

160

328

3.66

45.49

1.2

11.31

11.91

u/l

0.18

148

284

Any reimbursement code in KELA

192

272

3.55

45.43

1.3

1.2

11.99

17.79

u/l

3.69

175

249

Malignant neoplasm of breast, ER-positive, including Hilmo

160

328

3.65

45.39

1.2

11.31

11.91

u/l

0.18

148

284

Basal cell carcinoma

302

818

2.53

44.98

1.3

14.96

12.52

u/l

0.84

284

738

Malignant neoplasm of skin, including Hilmo

327

902

2.44

44.94

1.2

1.3

15.62

12.91

u/l

0.53

305

813

Complications of surgical and medical care, not elsewhere classified

655

2360

1.86

44.85

1.3

13.15

14.43

u/l

0.50

597

2182

malignant neoplasm of female genital organs, including Hilmo

113

247

4.41

44.44

1.2

1.3

11.05

10.46

u/l

0.23

108

213

Metabolic disorders

589

1836

1.93

44.23

1.3

13.17

14.89

u/l

0.67

534

1699

Pacemaker

390

1680

2.18

44.12

1.3

9.69

14.47

u/l

2.94

344

1553

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

311

856

2.47

43.74

1.2

1.3

16.68

12.53

u/l

0.86

289

772

Basal cell carcinoma, including Hilmo

306

842

2.48

43.44

1.2

1.3

14.90

12.57

u/l

0.79

286

759

Chronic lower respiratory diseases

715

2080

1.82

43.13

1.3

16.67

13.73

u/l

0.65

651

1924

Other CVD (FINNGEN)

101

156

5.01

42.66

1.4

1.2

15.79

15.75

u/l

0.00

148

Later onset COPD

344

1222

2.29

42.44

1.3

13.79

14.55

u/l

0.16

315

1122

Other malignant neoplasms of skin (=non-melanoma skin cancer)

300

836

2.45

41.72

1.3

14.57

12.51

u/l

0.71

278

753

Paroxysmal tachycardia

120

244

4.11

41.53

1.2

9.22

17.21

u/l

8.71

108

235

Iron deficiency anaemia

366

1679

2.16

40.82

1.3

13.12

14.27

u/l

0.24

321

1554

Hypertensive Heart Disease

240

688

2.68

40.78

1.3

10.79

14.61

u/l

2.00

219

654

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

123

209

4.19

40.75

1.2

15.06

12.90

u/l

0.48

108

199

Codeine

491

1323

2.01

40.37

1.2

1.3

12.33

14.79

u/l

1.84

450

1212

General symptoms and signs

589

1560

1.90

40.20

1.3

15.71

13.84

u/l

0.32

542

1454

Malignant neoplasm of digestive organs, including Hilmo

281

849

2.45

39.84

1.3

13.66

12.68

u/l

0.26

253

765

malignant neoplasm of female genital organs

224

4.37

38.89

1.2

1.3

11.13

10.59

u/l

0.19

191

Explicit bacterial Sepsis

120

326

3.74

38.22

1.2

1.3

15.98

11.63

u/l

0.57

107

306

Explicit bacterial Sepsis, including avohilmo

121

331

3.72

38.15

1.1

1.3

16.06

11.60

u/l

0.60

108

311

Unspecified kidney failure

134

394

3.47

37.96

1.2

1.3

9.27

13.78

u/l

2.36

116

362

Asthma-related infections

414

2039

1.99

37.41

1.2

1.3

13.85

14.61

u/l

0.20

370

1885

Asthma, hospital admission 2, infections

414

2039

1.99

37.41

1.2

1.3

13.85

14.61

u/l

0.20

370

1885

Other diseases of blood and blood-forming organs, wide

195

719

2.74

37.17

1.3

21.67

12.52

u/l

0.65

186

660

Cardiovascular diseases

177

295

3.19

36.88

1.3

1.2

11.72

19.62

u/l

6.88

165

281

Autoimmune diseases excluding thyroid diseases, strict definition

623

1890

1.80

36.87

1.3

16.45

14.13

u/l

0.73

564

1746

Diabetic nephropathy, excluding more controls

160

421

3.15

36.87

1.3

10.60

13.88

u/l

1.21

139

396

Gout

302

1163

2.25

36.56

1.3

13.49

13.73

u/l

0.03

269

1078

Autoimmune diseases excluding thyroid diseases

638

1950

1.78

36.39

1.3

16.32

14.04

u/l

0.73

575

1801

Hypo-osmolality and hyponatraemia

182

652

2.81

36.09

1.2

10.74

14.83

u/l

0.95

166

596

Pain in throat and chest

421

1238

2.02

35.88

1.3

1.2

13.64

15.05

u/l

0.44

380

1155

Other and unspecified iron deficiency

287

1288

2.24

35.54

1.3

13.59

14.37

u/l

0.12

257

1192

Pleural plaque with presence of asbestos

130

394

3.41

35.36

1.4

1.3

14.54

13.14

u/l

0.31

123

363

Complications of procedures, not elsewhere classified

524

2324

1.82

35.23

1.3

13.79

14.41

u/l

0.17

477

2149

Caries of dentine

194

712

2.65

34.46

1.3

18.33

15.62

u/l

0.32

183

651

Nutritional anaemias

401

1969

1.95

34.25

1.3

12.75

14.03

u/l

0.32

351

1831

Streptococcal septicaemia

106

286

3.78

34.19

1.2

1.3

16.89

13.81

u/l

0.29

261

Streptococcal septicaemia, including avohilmo

107

291

3.75

34.12

1.2

1.3

16.97

13.78

u/l

0.31

264

Complications of medical and surgical care

489

2413

1.83

33.85

1.3

12.65

14.10

u/l

0.57

436

2238

Care involving use of rehabilitation procedures

345

1523

2.05

33.33

1.3

1.2

13.38

14.66

u/l

0.32

286

1412

COPD-related respiratory insufficiency

148

501

3.01

33.25

1.3

12.73

12.83

u/l

0.02

130

460

Enterocolitis due to Clostridium difficile

126

388

3.31

33.20

1.4

1.3

11.50

12.56

u/l

0.21

107

350

L04AA Selective immunosuppressants

158

554

2.88

33.14

1.3

15.12

12.34

u/l

1.00

147

508

Gout, FINNGEN

302

1420

2.14

32.98

1.3

13.49

14.93

u/l

0.20

269

1312

Malignant neoplasm of urinary organs, including Hilmo

103

281

3.72

32.65

1.2

1.3

14.32

11.73

u/l

0.45

251

Adjustment and management of implanted device

177

665

2.70

32.63

1.3

9.43

13.75

u/l

3.39

168

611

Hernia of abdominal wall, postoperative

106

292

3.63

32.61

1.2

15.31

14.30

u/l

0.16

268

Malignant neoplasm of digestive organs

250

824

2.33

32.36

1.3

13.95

12.60

u/l

0.34

222

743

Calcific aortic valvular stenosis, operated

316

1476

2.08

32.15

1.4

1.3

17.45

12.78

u/l

0.44

283

1358

Calcific aortic valvular stenosis

316

1476

2.08

32.15

1.4

1.3

17.45

12.78

u/l

0.44

283

1358

Operations 2 for CAVS

316

1476

2.08

32.15

1.4

1.3

17.45

12.78

u/l

0.44

283

1358

Calcific aortic valvular stenosis, diagnosis (helper)

316

1476

2.08

32.15

1.4

1.3

17.45

12.78

u/l

0.44

283

1358

Calcific aortic valvular stenosis, including rheumatic fever

316

1482

2.07

31.71

1.4

1.3

17.45

12.77

u/l

0.44

283

1364

Secondary hypertension

110

5.53

31.67

1.2

11.64

15.80

u/l

1.50

104

Type 2 diabetes, wide definition

511

1800

1.80

31.29

1.3

12.13

14.93

u/l

1.71

468

1671

Cardiodefibrillation

329

1643

2.02

30.88

1.3

13.89

14.35

u/l

0.04

304

1515

Cough

243

1004

2.27

30.84

1.3

1.2

13.17

14.35

u/l

0.56

219

941

Dental caries

205

797

2.45

30.78

1.3

1.2

18.11

15.37

u/l

0.36

194

723

Other respiratory diseases principally affecting the interstitium

194

789

2.49

30.46

1.3

14.25

14.94

u/l

0.11

170

718

Serous carcinoma of ovary, including Hilmo

9.47

30.14

1.2

10.03

8.41

u/l

0.65

Percutaneous Coronary Intervention

482

1625

1.81

30.05

1.3

15.61

14.93

u/l

0.08

433

1518

STROKE

328

1083

2.05

30.02

1.3

1.2

12.93

14.86

u/l

0.71

288

1021

Other bacterial intestinal infections

165

625

2.67

29.96

1.4

1.3

12.21

14.44

u/l

0.38

145

578

Peripheral artery disease

401

1691

1.89

29.88

1.3

9.89

14.82

u/l

4.29

352

1573

Certain infectious and parasitic diseases, including avohilmo

383

982

1.96

28.95

1.3

12.84

13.03

u/l

0.05

356

916

Malignant neoplasm of urinary organs

241

3.75

28.59

1.2

1.3

15.25

11.85

u/l

0.53

213

Emergency coronary revascularization (for ACS)

541

1902

1.72

28.53

1.3

15.29

14.43

u/l

0.11

485

1773

Implicit fungal Sepsis, including avohilmo

194

4.10

28.26

1.5

1.3

10.15

11.45

u/l

0.40

184

Hyperkalaemia

212

3.96

28.24

1.3

1.2

9.67

12.78

u/l

0.94

192

Other acute lower respiratory infections

369

1881

1.88

28.14

1.3

15.75

14.46

u/l

0.23

343

1732

Diseases of oesophagus, stomach and duodenum

614

2190

1.66

28.11

1.3

13.41

14.75

u/l

0.47

558

2023

COPD, hospital admissions 1, only main diagnosis

330

1458

1.96

28.05

1.2

1.3

13.54

14.46

u/l

0.21

305

1346

Hypertension, essential

366

1069

1.94

27.80

1.3

1.2

13.89

15.55

u/l

0.51

331

1008

Hard cardiovascular diseases

470

1564

1.78

27.68

1.3

15.73

15.15

u/l

0.06

422

1461

Insulin medication

416

1914

1.81

27.67

1.4

1.3

11.80

14.84

u/l

1.80

367

1773

Coronary revascularization (ANGIO or CABG)

473

1625

1.77

27.65

1.3

15.75

14.93

u/l

0.09

424

1518

Ischemic heart diseases

484

1640

1.76

27.57

1.3

15.44

14.91

u/l

0.06

430

1533

Dialysis

5.83

27.35

1.2

8.50

13.24

u/l

1.09

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

245

3.64

27.16

1.2

15.02

12.07

u/l

0.45

216

Bacterial intestinal infections, IBD co-morbidities

163

645

2.56

27.13

1.4

1.3

12.15

12.56

u/l

0.10

144

588

Oedema, not elsewhere classified

239

1093

2.15

26.78

1.4

1.3

11.25

13.35

u/l

0.87

214

1020

Intestinal infectious diseases

552

2473

1.66

26.76

1.3

13.66

14.48

u/l

0.30

490

2296

Pure hypercholesterolaemia

482

1763

1.74

26.75

1.3

13.83

14.84

u/l

0.36

437

1631

Enlarged lymph nodes

123

424

2.93

26.72

1.3

24.63

12.84

u/l

0.51

116

392

Anaemia in chronic diseases classified elsewhere

6.23

26.59

1.2

11.13

13.13

u/l

0.26

Hypertensive diseases

364

1076

1.91

26.55

1.3

1.2

12.94

15.55

u/l

1.38

330

1015

Hypertension

363

1076

1.91

26.26

1.3

1.2

12.96

15.55

u/l

1.37

329

1015

Other bacterial intestinal infections, including avohilmo

183

785

2.35

25.54

1.3

12.11

14.48

u/l

0.51

159

722

Other disorders of skin and subcutaneous tissue

477

2380

1.70

25.50

1.3

13.22

14.22

u/l

0.23

430

2200

Fibrosis and cirrhosis of liver

261

3.48

25.48

1.4

1.3

9.81

12.05

u/l

1.08

237

Gout, idiopatic and unspecified

250

1222

2.07

25.28

1.3

10.50

14.20

u/l

2.61

224

1130

Reimbursement for rheumatic diseases

338

1817

1.86

25.18

1.3

15.80

14.01

u/l

0.78

317

1672

643

2036

1.61

25.02

1.3

13.74

13.99

u/l

0.08

592

1887

Malignant neoplasm of kidney, except renal pelvis

221

3.67

25.02

1.2

15.68

10.59

u/l

0.86

194

Parasetamol

346

914

1.92

24.79

1.3

15.00

13.26

u/l

0.58

317

851

Atherosclerosis, excluding cerebral and coronary sclerosis

374

1634

1.81

24.57

1.3

9.88

14.83

u/l

4.12

328

1520

Disorders of lipoprotein metabolism and other lipidaemias

496

1791

1.69

24.49

1.3

13.86

14.83

u/l

0.29

451

1656

Fungal Sepsis

119

4.74

23.91

1.4

1.2

11.93

12.42

u/l

0.08

110

L04AX Other immunosuppressants

317

1712

1.86

23.76

1.3

18.87

14.23

u/l

1.10

297

1581

Major coronary heart disease event

496

1777

1.68

23.69

1.3

15.31

14.74

u/l

0.06

440

1661

Bronchitis

625

2379

1.58

23.67

1.3

13.35

14.19

u/l

0.40

576

2190

ILD, hospital admissions

159

667

2.42

23.49

1.3

14.66

13.05

u/l

0.41

143

613

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

142

566

2.54

23.41

1.4

1.3

15.38

13.31

u/l

0.25

132

522

Diabetic nephropathy

162

677

2.40

23.41

1.3

10.52

13.47

u/l

1.07

141

627

Second line medication for Crohn's disease

320

1748

1.84

23.10

1.3

18.83

14.23

u/l

1.11

300

1612

Other interstitial pulmonary diseases

160

679

2.39

23.04

1.3

14.90

13.07

u/l

0.49

144

620

Interstitial lung disease

160

680

2.38

22.96

1.3

14.90

12.99

u/l

0.52

144

623

Interstitial lung disease endpoints

160

680

2.38

22.96

1.3

14.90

12.99

u/l

0.52

144

623

Diseases of the digestive system

346

1929

1.79

22.88

1.3

12.72

14.17

u/l

0.33

308

1785

Asthma/COPD (KELA code 203)

507

2078

1.63

22.60

1.3

13.68

13.73

u/l

0.01

462

1923

Implicit fungal Sepsis

109

4.80

22.52

1.4

1.2

10.71

12.14

u/l

0.27

101

Insulin, fast-acting

246

1246

1.99

22.46

1.4

1.3

11.64

15.33

u/l

1.41

215

1148

Diarrhoea and gastroenteritis of presumed infectious origin

403

2110

1.71

22.45

1.3

13.91

14.72

u/l

0.23

358

1962

Early onset COPD

172

763

2.28

22.30

1.2

1.3

13.55

12.90

u/l

0.15

159

711

Nonischemic cardiomyopathy

102

352

2.94

22.24

1.2

1.3

15.33

13.07

u/l

0.19

327

Codeine or tramadol medication

622

2165

1.56

22.17

1.2

1.3

13.28

14.72

u/l

0.62

572

1997

Coronary atherosclerosis

415

1528

1.72

22.10

1.3

12.25

15.07

u/l

1.41

370

1429

Ulcer of lower limb, not elsewhere classified

145

604

2.43

21.78

1.4

1.3

10.24

12.61

u/l

1.27

135

548

Abnormal findings on diagnostic imaging of other body structures

102

357

2.89

21.67

1.5

1.3

11.56

12.24

u/l

0.22

326

Abnormal findings on examination of blood, without diagnosis

360

1879

1.74

21.45

1.3

12.98

14.54

u/l

0.70

323

1747

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

388

2247

1.70

21.43

1.3

12.43

14.17

u/l

0.62

347

2086

Infections of the skin and subcutaneous tissue

336

1876

1.77

21.42

1.3

18.62

14.47

u/l

0.44

311

1731

Use of hypnotics and sedatives

596

2186

1.56

21.38

1.2

1.3

14.71

14.40

u/l

0.08

547

2019

Cardiomyopathy, other and unspecified

166

3.85

21.14

1.5

1.2

14.88

14.52

u/l

0.02

160

Unspecified acute lower respiratory infection

121

469

2.61

21.14

1.2

1.3

12.97

14.04

u/l

0.30

105

429

Other dialysis

5.16

21.04

1.3

1.2

8.18

10.52

u/l

0.84

Other diseases of the digestive system

273

1466

1.88

21.04

1.3

13.11

14.61

u/l

0.26

241

1354

Dipeptidyl peptidase 4 (DPP-4) inhibitors

410

1921

1.68

20.97

1.3

12.39

14.13

u/l

0.94

373

1777

Insulin, combination of fast acting with intermediate-acting or long-acting

416

2277

1.66

20.95

1.4

1.3

11.80

14.62

u/l

1.84

367

2115

GI-bleeding

274

1475

1.87

20.94

1.3

13.13

14.66

u/l

0.26

241

1363

Kidney transplant status

108

4.62

20.82

1.3

1.2

7.17

11.46

u/l

3.16

100

Substance abuse, excluding more controls

355

1712

1.74

20.81

1.2

1.3

14.82

14.80

u/l

0.00

328

1591

Non-follicular lymphoma

101

363

2.83

20.54

1.4

1.3

29.48

11.82

u/l

1.43

331

Gout, strict definition

188

898

2.12

20.37

1.4

1.3

9.68

14.10

u/l

2.69

167

829

Cerebrovascular diseases

498

2172

1.60

20.31

1.3

11.65

14.47

u/l

2.18

443

2018

Disorders of lens

413

1529

1.68

20.25

1.3

12.54

13.90

u/l

0.83

370

1424

Fall on same level

586

2017

1.55

20.19

1.3

14.18

14.86

u/l

0.19

525

1881

Small cell lung cancer, including Hilmo

5.87

19.86

1.2

11.06

10.00

u/l

0.23

Small cell lung cancer

5.87

19.86

1.2

11.06

10.00

u/l

0.23

Volume depletion

354

2.81

19.73

1.2

8.80

13.60

u/l

2.61

323

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

128

241

2.67

19.70

1.2

12.39

15.61

u/l

0.88

116

227

Diseases of liver

232

1208

1.93

19.67

1.4

1.3

14.35

14.79

u/l

0.06

211

1115

Insulin, fast-acting or short human

247

1312

1.89

19.66

1.4

1.3

11.67

15.12

u/l

1.32

216

1208

Major coronary heart disease event excluding revascularizations

405

1606

1.67

19.65

1.3

12.78

14.42

u/l

0.51

353

1505

370

1969

1.68

19.55

1.3

14.53

14.42

u/l

0.03

340

1824

Antihypertensive medication - note that there are other indications

175

405

2.26

19.45

1.3

1.2

10.67

17.72

u/l

7.62

160

385

ILD, hospital admissions 1, main diag only

139

599

2.35

19.43

1.3

15.27

12.92

u/l

0.58

123

550

Autoimmune diseases

591

1954

1.54

19.40

1.3

15.97

14.04

u/l

0.52

542

1805

Diabetes, varying definitions

514

1894

1.58

19.34

1.3

12.43

15.04

u/l

1.55

468

1755

Gout, unspecified

198

985

2.03

19.24

1.3

10.31

14.44

u/l

2.30

178

911

Hypokalaemia

100

370

2.73

19.22

1.2

15.37

16.05

u/l

0.04

339

Diabetes mellitus

515

1894

1.57

19.20

1.3

12.46

15.06

u/l

1.55

470

1755

Myocardial infarction

342

1393

1.72

18.83

1.3

12.42

14.43

u/l

0.74

296

1303

Mental and behavioural disorders due to psychoactive substance use

364

2001

1.67

18.81

1.2

1.3

14.72

15.01

u/l

0.06

337

1853

Substance abuse

355

1971

1.68

18.70

1.2

1.3

14.82

14.98

u/l

0.03

328

1823

Asthma (diagnoses ohter than nonallergic)

485

2518

1.56

18.52

1.3

13.39

14.33

u/l

0.32

439

2329

Type 2 diabetes

508

1885

1.56

18.46

1.3

12.60

14.98

u/l

1.34

464

1747

Insulin, intermediate and long-acting

367

2147

1.66

18.42

1.4

1.3

11.44

14.83

u/l

2.25

320

1991

Injuries to the head

596

2356

1.50

18.25

1.3

15.27

14.16

u/l

0.38

542

2180

Persons encountering health services in other circumstances, wide

630

2172

1.49

18.15

1.3

14.31

14.48

u/l

0.04

601

1983

Iron deficiency anaemia secondary to blood loss (chronic)

132

573

2.33

18.13

1.3

13.69

12.17

u/l

0.19

110

526

Used for control exclusion in common control thyroid runs

552

1814

1.54

18.10

1.3

14.60

14.29

u/l

0.08

507

1677

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

277

2.97

18.09

1.4

1.3

13.21

12.70

u/l

0.09

256

Peripheral arterial reconstruction

173

841

2.08

17.96

1.3

9.18

13.75

u/l

4.95

149

772

Alcohol use disorder, Swedish definition

351

1922

1.67

17.90

1.3

14.62

14.41

u/l

0.05

323

1781

All influenza (not pneumonia)

226

3.16

17.84

1.3

15.22

12.43

u/l

0.56

221

Seropositive rheumatoid arthritis

175

851

2.06

17.79

1.3

19.23

12.32

u/l

4.41

165

785

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

551

2302

1.52

17.77

1.3

14.99

14.14

u/l

0.19

500

2131

Amputation

107

427

2.54

17.73

1.3

9.10

13.95

u/l

2.50

393

Benign neoplasm of colon, rectum, anus and anal canal

436

2342

1.58

17.72

1.3

11.89

14.22

u/l

1.23

408

2151

Invasive ventilation

218

3.21

17.65

1.3

11.59

13.96

u/l

0.49

198

Emphysema

271

2.96

17.56

1.2

1.3

19.46

12.33

u/l

0.75

251

375

2005

1.63

17.56

1.3

14.50

15.13

u/l

0.15

345

1859

Acute bronchitis

271

1507

1.77

17.48

1.3

16.50

14.46

u/l

0.30

257

1388

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

489

1873

1.55

17.35

1.3

11.88

14.99

u/l

2.23

443

1736

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

170

834

2.05

17.17

1.3

19.47

13.68

u/l

1.80

160

763

Rheumatoid arthritis

220

1039

1.89

17.05

1.3

1.2

18.37

13.05

u/l

3.21

209

957

Seropositive rheumatoid arthritis, wide

175

870

2.03

17.05

1.3

19.23

13.56

u/l

1.84

165

797

Malignant neoplasm of breast, ER-negative, including Hilmo

291

2.78

16.99

1.2

10.32

10.75

u/l

0.11

249

Osteopathies and chondropathies

330

1815

1.67

16.95

1.3

12.27

14.47

u/l

1.14

291

1680

Clear cell adenocarcinoma of kidney

101

4.33

16.93

1.2

1.3

10.50

10.17

u/l

0.08

Acute peritonitis

204

3.24

16.84

1.2

1.3

10.13

12.11

u/l

0.75

188

Malignant neoplasm of breast, HER-negative

276

2.83

16.70

1.2

10.60

10.86

u/l

0.06

237

Bronchiectasis

252

2.98

16.68

1.4

1.3

40.05

11.26

u/l

0.77

237

Other/unspecified seropositive rheumatoid arthritis

172

858

2.02

16.61

1.3

19.27

13.59

u/l

1.81

162

785

Senile cataract

393

1484

1.62

16.59

1.3

12.44

13.89

u/l

0.87

350

1382

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

101

400

2.52

16.59

1.3

13.61

11.00

u/l

0.59

356

Disorders of choroid and retina

505

2340

1.52

16.56

1.3

12.29

14.25

u/l

0.90

456

2171

Glomerulonephritis

271

2.88

16.34

1.4

1.3

15.66

13.49

u/l

0.26

249

Lung transplantation

20.03

16.31

1.1

8.96

12.77

u/l

0.56

Symptoms and signs involving the urinary system

460

2265

1.54

16.30

1.3

12.89

14.11

u/l

0.56

424

2085

Abnormalities of heart beat

188

942

1.94

16.29

1.3

1.2

9.74

14.33

u/l

6.01

162

882

Disorders of gallbladder, biliary tract and pancreas

558

2346

1.48

16.22

1.3

16.00

13.83

u/l

0.35

509

2167

Rheumatoid arthritis, including avohilmo

232

1292

1.81

16.03

1.3

18.20

13.59

u/l

1.95

220

1179

Convulsions, not elsewhere classified

131

589

2.21

16.02

1.3

17.63

14.68

u/l

0.33

120

546

Squamous cell neoplasms and carcinomas of the skin

314

2.70

15.89

1.3

13.61

11.43

u/l

0.37

277

Secondary malignant neoplasm of respiratory and digestive organs

6.79

15.84

1.3

11.32

10.13

u/l

0.25

Diagnoses used for exclusion with ILD

189

991

1.92

15.83

1.4

1.3

13.12

15.33

u/l

0.59

177

908

Disorders resulting from impaired renal tubular function

111

4.06

15.83

1.2

8.56

11.39

u/l

1.04

Amputation of toe

288

2.79

15.77

1.3

9.52

14.40

u/l

1.66

260

Other CVD

179

928

1.95

15.54

1.3

12.72

15.19

u/l

0.36

160

844

Medicines for HER+ breast cancer

173

821

1.97

15.54

1.2

1.3

11.68

13.54

u/l

0.42

161

744

Lung transplant status

19.14

15.43

1.1

8.74

12.77

u/l

0.60

Other diseases of intestines

520

1942

1.49

15.38

1.3

17.03

14.10

u/l

0.47

471

1801

Gastroduodenal ulcer

216

1190

1.82

15.35

1.3

13.38

14.92

u/l

0.21

196

1111

Persons encountering health services for other counselling and medical advice, not elsewhere classified

589

2153

1.46

15.17

1.3

13.99

14.54

u/l

0.12

552

1966

Mental and behavioural disorders due to alcohol, excluding acute intoxication

277

1634

1.69

15.12

1.3

14.95

14.65

u/l

0.06

256

1520

Colorectal cancer, including Hilmo

151

691

2.05

15.08

1.3

13.65

12.43

u/l

0.22

137

624

Dilated cardiomyopathy

110

480

2.32

15.06

1.2

1.3

12.53

13.19

u/l

0.05

443

Malignant melanoma

382

2.48

15.02

1.3

10.24

11.73

u/l

0.80

343

Other cataract

290

1286

1.68

14.96

1.3

12.32

13.75

u/l

0.53

271

1204

Hyperlipidaemia, other/unspecified

276

1481

1.68

14.70

1.4

1.3

12.19

14.12

u/l

0.52

253

1374

Constipation

512

2359

1.47

14.70

1.3

13.94

13.98

u/l

0.01

464

2181

Stroke, including SAH

429

2025

1.53

14.66

1.3

11.25

14.18

u/l

2.36

383

1885

Seropositive rheumatoid arthritis, strict definition

100

423

2.38

14.66

1.3

19.86

15.32

u/l

0.58

387

Other disorders of kidney and ureter

106

461

2.32

14.62

1.3

10.24

12.52

u/l

0.95

423

Diabetes, insulin treatment (Kela reimbursement)

535

2177

1.47

14.58

1.3

12.27

14.86

u/l

1.72

488

2016

Type 1 diabetes, wide definition, subgroup 1

109

481

2.28

14.43

1.3

10.00

14.36

u/l

2.44

444

Fracture of femur

225

1155

1.77

14.25

1.2

1.3

12.98

13.94

u/l

0.15

205

1049

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

342

2174

1.57

14.20

1.3

12.70

14.05

u/l

0.39

306

2011

Ischaemic heart disease, wide definition

438

1783

1.52

14.19

1.3

16.01

14.56

u/l

0.16

392

1660

Osteoporosis

185

915

1.87

14.15

1.3

11.82

13.23

u/l

0.33

164

836

Endocrine, nutritional and metabolic diseases

327

1010

1.64

14.11

1.3

13.47

16.74

u/l

0.85

300

947

Malignant melanoma, including Hilmo

101

437

2.33

14.07

1.3

10.35

11.46

u/l

0.58

394

Idiopathic gout

421

2.36

13.96

1.4

1.3

10.76

13.88

u/l

1.44

388

Syncope and collapse

268

1340

1.68

13.94

1.3

14.35

13.44

u/l

0.18

242

1250

Nausea and vomiting

167

855

1.91

13.92

1.3

1.2

13.31

12.45

u/l

0.19

145

789

Purpura and other haemorrhagic conditions

427

2.34

13.92

1.3

15.13

13.10

u/l

0.48

391

Other retinal disorders

425

2151

1.51

13.84

1.3

11.12

14.14

u/l

2.49

383

1997

Certain disorders involving the immune mechanism

116

536

2.18

13.82

1.5

1.3

14.74

12.99

u/l

0.48

110

494

Factors influencing health status and contact with health services

148

355

2.10

13.78

1.3

1.2

12.61

15.32

u/l

0.79

135

335

Mental and behavioural disorders due to alcohol

307

1829

1.60

13.73

1.2

1.3

14.65

14.55

u/l

0.02

284

1693

Autoimmune diseases related-to ILD

435

2444

1.49

13.67

1.3

16.99

13.83

u/l

0.78

390

2262

Alcoholic liver disease

348

2.47

13.46

1.3

19.40

14.04

u/l

0.43

324

Sulfasalazine

147

749

1.97

13.46

1.4

1.2

17.15

15.03

u/l

0.39

142

701

Alcohol use disorder, ICD-based

252

1513

1.67

13.41

1.3

15.38

14.65

u/l

0.14

233

1404

Hodgkin lymphoma, hilmo

4.79

13.35

1.2

10.73

10.89

u/l

0.03

Peripheral artery operations in Hilmo

116

544

2.15

13.35

1.3

9.15

14.08

u/l

3.26

100

501

In situ neoplasms

261

1584

1.66

13.34

1.2

1.3

13.96

13.65

u/l

0.06

246

1448

Hypertensive Renal Disease

145

3.38

13.33

1.4

1.2

7.20

12.20

u/l

4.30

136

Open wound of head

338

2049

1.55

13.19

1.3

13.36

14.33

u/l

0.32

312

1900

Intestinal infectious diseases, including avohilmo, including avohilmo

608

2413

1.41

13.14

1.3

13.74

14.39

u/l

0.23

544

2241

Lung diseases due to external agents

123

597

2.08

12.97

1.4

1.3

11.75

13.63

u/l

0.73

114

540

Symptoms and signs involving the digestive system and abdomen

520

1804

1.45

12.92

1.3

17.17

14.16

u/l

0.47

471

1679

L02BA Anti-estrogens

337

2.45

12.85

1.3

1.2

10.47

15.39

u/l

0.56

307

Type 2 diabetes, definitions combined

469

1866

1.47

12.81

1.3

12.64

14.97

u/l

1.25

429

1728

Misadventures to patients during surgical and medical care

444

2.25

12.74

1.4

1.3

13.83

12.79

u/l

0.16

409

Injuries to the abdomen, lower back, lumbar spine and pelvis

251

1504

1.65

12.72

1.3

16.15

14.06

u/l

0.39

227

1382

Abnormal results of function studies

180

3.03

12.70

1.4

1.3

11.15

12.25

u/l

0.26

167

Stroke, excluding SAH

410

1992

1.49

12.65

1.3

10.94

14.13

u/l

2.70

365

1852

Other soft tissue disorders, not elsewhere classified

480

1879

1.46

12.63

1.3

12.46

14.27

u/l

1.42

438

1745

Type 2 diabetes, strict (exclude DM1)

471

1884

1.46

12.53

1.3

12.79

14.92

u/l

1.08

431

1743

Colorectal cancer

133

643

1.99

12.52

1.3

13.87

11.80

u/l

0.37

120

580

Hernia

485

2240

1.44

12.48

1.2

1.3

14.12

14.20

u/l

0.02

450

2063

Injuries to the hip and thigh

330

1922

1.55

12.48

1.3

12.95

14.12

u/l

0.31

307

1771

Coagulation defects, purpura and other haemorrhagic conditions

125

620

2.03

12.41

1.3

14.28

12.51

u/l

0.56

117

573

Type 1 diabetes

130

657

1.99

12.18

1.3

10.02

14.54

u/l

3.35

113

610

L02BG Aromatase inhibitors

145

752

1.91

12.17

1.2

1.3

11.85

13.61

u/l

0.35

135

680

Intracranial trauma

276

1155

1.62

12.17

1.3

14.47

15.03

u/l

0.12

245

1080

Cardiac arrest

106

3.47

12.11

1.2

8.94

16.03

u/l

3.64

100

Pain, not elsewhere classified

141

736

1.92

12.08

1.3

14.15

13.66

u/l

0.11

131

683

Diseases of the skin and subcutaneous tissue

491

1710

1.44

12.07

1.3

12.30

14.08

u/l

1.58

453

1577

Type 1 diabetes, wide definition

113

546

2.08

12.01

1.3

9.97

14.09

u/l

2.48

507

Tuberculosis, IBD comorbidity

265

2.60

12.00

1.4

1.2

24.19

12.83

u/l

2.87

244

Persons with potential health hazards related to communicable diseases

130

656

1.97

11.94

1.2

1.3

17.89

13.73

u/l

0.56

117

608

Ischaemic Stroke, excluding all haemorrhages

395

1969

1.48

11.91

1.3

11.33

14.05

u/l

1.89

353

1834

Tuberculosis

243

2.67

11.91

1.4

1.2

25.80

13.69

u/l

2.79

224

Diabetic retinopathy, excluding more controls

160

473

1.90

11.78

1.3

12.56

13.74

u/l

0.16

139

443

Lymphoid leukaemia

194

2.88

11.78

1.4

1.3

37.64

11.99

u/l

0.47

178

215

1273

1.68

11.74

1.2

1.3

12.23

14.25

u/l

0.80

200

1172

Myocardial infarction, strict

297

1342

1.57

11.72

1.3

12.27

14.47

u/l

0.74

260

1255

Fracture of lumbar spine and pelvis

166

921

1.81

11.70

1.3

16.68

14.16

u/l

0.30

147

843

Hypotension

151

817

1.86

11.66

1.3

13.87

13.72

u/l

0.02

132

745

Polyneuropathies and other disorders of the peripheral nervous system

163

903

1.82

11.66

1.3

10.56

16.08

u/l

2.28

143

829

Exposure to unspecified factor

517

2508

1.40

11.61

1.2

1.3

13.58

14.44

u/l

0.30

476

2310

Multiple myeloma, including Hilmo

108

3.57

11.59

1.3

10.56

10.42

u/l

0.02

Other arthritis (FG)

177

1007

1.77

11.54

1.3

15.08

13.83

u/l

0.34

165

938

Asthma and allergy

12.36

11.50

1.5

1.2

9.90

16.38

u/l

0.23

Dermatitis

341

2232

1.50

11.39

1.3

14.05

14.19

u/l

0.04

315

2053

Benign neoplasm: Colon

359

2277

1.48

11.38

1.3

10.95

14.36

u/l

2.67

333

2095

Disorders of thyroid, IBD co-morbidities

235

2.40

11.37

1.4

1.2

11.92

12.88

u/l

0.30

222

Retention of urine

268

1370

1.59

11.32

1.3

13.29

14.02

u/l

0.25

248

1271

Malignant melanoma of skin

273

2.51

11.27

1.3

9.67

11.80

u/l

1.05

240

Other special examinations and investigations of persons without complaint or reported diagnosis

339

1124

1.53

11.19

1.3

1.2

12.89

14.16

u/l

0.67

313

1053

Respiratory tuberculosis, confirmed and not-confirmed

211

2.74

11.17

1.4

1.3

27.22

14.55

u/l

2.59

194

Respiratory tuberculosis

211

2.74

11.17

1.4

1.3

27.22

14.55

u/l

2.59

194

Type 2 diabetes, definitions combined, including avohilmo

461

1867

1.43

11.16

1.3

12.81

14.96

u/l

1.09

421

1727

Other disorders of skin and subcutaneous tissue, not elsewhere classified

100

477

2.11

11.10

1.3

10.98

12.60

u/l

0.60

435

Fracture of rib(s), sternum and thoracic spine

212

1283

1.66

11.07

1.2

1.3

14.17

14.99

u/l

0.17

199

1177

Cutaneous abscess, furuncle and carbuncle

141

759

1.87

11.05

1.3

24.64

13.52

u/l

0.53

128

704

Paralytic ileus and intestinal obstruction

182

1062

1.72

10.87

1.3

14.59

12.73

u/l

0.34

167

986

Pain in limb

421

1859

1.44

10.85

1.3

12.26

14.27

u/l

1.56

386

1728

Pneumonia derived septicemia

3.68

10.83

1.3

18.24

12.76

u/l

1.02

Systemic connective tissue disorders

201

1209

1.67

10.75

1.3

13.86

13.59

u/l

0.06

181

1107

Tuberculosis, wide

280

2.46

10.74

1.4

1.3

24.19

13.54

u/l

2.56

258

Diseases of peritoneum

324

2.34

10.63

1.2

1.3

11.18

12.91

u/l

0.48

296

Other embolism and thrombosis

439

2.14

10.63

1.3

22.88

12.74

u/l

0.54

406

Falls/tendency to fall

494

1762

1.41

10.63

1.3

12.07

14.93

u/l

1.68

442

1648

Intestinal stricture

210

1282

1.65

10.62

1.3

14.05

14.59

u/l

0.08

191

1185

Tuberculosis, wide, including avohilmo

282

2.44

10.58

1.4

1.3

24.19

13.49

u/l

2.59

260

Diabetes medication

502

2107

1.39

10.57

1.3

12.36

14.87

u/l

1.63

456

1947

Substance use, excluding alcohol

427

2.14

10.53

1.2

1.3

19.41

13.51

u/l

0.59

398

Gastric ulcer

136

738

1.86

10.45

1.3

1.2

12.75

15.04

u/l

0.28

120

679

Other specified/unspecified arthritis

158

897

1.77

10.44

1.3

15.31

13.82

u/l

0.38

147

834

Other (seronegative) rheumatoid arthritis, wide

115

591

1.96

10.42

1.3

16.08

14.99

u/l

0.14

110

535

Malignant neoplasm of colon, including Hilmo

103

509

2.03

10.29

1.3

12.83

11.35

u/l

0.32

457

Malignant melanoma of skin, including Hilmo

344

2.25

10.09

1.2

1.3

9.91

11.38

u/l

0.73

306

Amiodarone users

423

2.13

10.06

1.2

1.3

26.95

13.21

u/l

0.39

389

Other and unspecified dermatitis

278

1835

1.52

10.04

1.3

13.60

14.41

u/l

0.27

257

1690

Presence of other functional implants

357

1679

1.46

9.99

1.3

16.66

13.94

u/l

0.27

326

1571

Hepatic failure, not elsewhere classified

115

3.27

9.89

1.5

1.2

14.41

11.73

u/l

0.23

103

Cellulitis

132

725

1.83

9.78

1.4

1.3

16.13

13.38

u/l

0.38

125

667

Benign neoplasms

474

1860

1.39

9.70

1.3

13.96

14.58

u/l

0.13

445

1708

Methotrexate

339

2.23

9.58

1.3

17.03

17.51

u/l

0.04

316

Fitting and adjustment of other devices

209

1148

1.61

9.54

1.4

1.3

11.52

13.66

u/l

1.59

197

1068

Other and unspecified polyneuropathies, also in other diseases

142

808

1.77

9.40

1.3

10.45

13.95

u/l

2.53

127

741

Asthma and opportunity respiratory infection

152

2.87

9.25

1.3

14.92

11.71

u/l

0.81

141

Unspecified haematuria

290

1594

1.49

9.19

1.3

13.96

14.67

u/l

0.16

268

1472

Mycoses

160

948

1.70

9.15

1.3

12.65

14.48

u/l

0.48

138

875

Coronary artery bypass grafting

203

939

1.61

9.06

1.3

9.87

15.22

u/l

7.14

183

877

Left ventricular outflow tract obstruction (LVOTO), broad definition

223

2.49

9.01

1.4

1.3

13.91

12.34

u/l

0.17

210

Phlebitis and thrombophlebitis (not including DVT)

131

738

1.78

8.97

1.3

14.11

14.93

u/l

0.13

118

686

Diverticular disease of intestine

407

1815

1.40

8.95

1.3

14.18

13.45

u/l

0.24

376

1684

Pneumococcal septicemia

3.35

8.93

1.3

1.2

18.56

13.15

u/l

0.95

Symptoms and signs involving cognition, perception, emotional state and behaviour

483

2383

1.36

8.91

1.3

14.08

14.40

u/l

0.08

437

2212

Type of accident

154

910

1.70

8.90

1.3

16.90

14.98

u/l

0.21

133

842

Malignant neoplasm of bladder, including Hilmo

404

2.07

8.89

1.3

13.16

11.43

u/l

0.31

365

Viral infections characterized by skin and mucous membrane lesions

210

1341

1.57

8.85

1.3

13.32

14.12

u/l

0.19

189

1246

Chronic apical periodontitis

545

2291

1.34

8.82

1.3

15.23

14.05

u/l

0.35

509

2098

Chronic ulcer of skin, not elsewhere classified

251

2.38

8.75

1.3

10.17

14.01

u/l

1.11

228

Unspecified fall

288

1936

1.46

8.72

1.3

15.71

13.97

u/l

0.39

257

1787

Osteomyelitis

221

2.47

8.72

1.3

10.66

12.27

u/l

0.42

201

Supplementary factors related to causes of morbidity and mortality classified elsewhere

163

985

1.66

8.67

1.3

16.88

14.93

u/l

0.23

141

914

Other symptoms and signs involving the urinary system

381

2.09

8.64

1.4

1.3

11.21

13.28

u/l

0.64

354

Elevated blood glucose level

228

2.43

8.62

1.2

1.3

16.48

11.56

u/l

0.90

210

Injuries to the thorax

279

1904

1.47

8.62

1.3

13.64

14.89

u/l

0.39

262

1749

Persons encountering health services in other circumstances

200

1259

1.58

8.60

1.2

1.3

11.72

15.69

u/l

1.90

194

1148

Open wound of lower leg

422

2.03

8.58

1.4

1.3

13.55

12.77

u/l

0.15

387

Finngen Rheumatological endpoints

434

1796

1.37

8.46

1.3

13.68

13.56

u/l

0.05

398

1662

Colorectal adenocarcinoma

109

584

1.85

8.43

1.2

1.3

10.65

11.90

u/l

0.62

528

Use of anticholinesterases

127

1670

0.58

8.35

1.2

1.3

18.88

13.28

u/l

0.88

115

1528

N06DA Anticholinesterases

127

1670

0.58

8.35

1.2

1.3

18.88

13.28

u/l

0.88

115

1528

Malignant neoplasm of colon

421

2.01

8.27

1.3

12.63

11.28

u/l

0.22

376

Other external causes of accidental injury

377

1347

1.40

8.20

1.3

12.67

14.14

u/l

0.52

344

1254

Vascular disorders of the intestines

278

2.25

8.17

1.3

16.47

10.81

u/l

0.40

251

Other viral diseases

114

632

1.80

8.16

1.3

12.56

13.93

u/l

0.48

106

588

Small cell lung cancer, helper endpoint

125

2.94

8.07

1.2

11.06

11.95

u/l

0.16

115

Obesity related asthma

172

1075

1.61

8.04

1.4

1.3

13.47

14.53

u/l

0.20

158

1000

Candidiasis, including avohilmo

138

819

1.69

7.91

1.4

1.3

12.81

14.27

u/l

0.29

127

754

Other gastritis (incl. Duodenitis)

138

823

1.69

7.79

1.4

1.3

11.26

15.19

u/l

1.27

122

763

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.69

7.76

1.3

9.32

10.75

u/l

0.20

Multiple myeloma

3.69

7.76

1.3

9.32

10.75

u/l

0.20

Other or unspecified ileus, impaction or obstruction

126

735

1.72

7.71

1.2

1.3

15.46

13.10

u/l

0.29

114

680

Aortic valve malfunction, age under 60 years

210

2.40

7.66

1.4

1.3

14.76

12.29

u/l

0.25

198

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

211

2.39

7.59

1.4

1.2

15.81

12.13

u/l

0.35

193

Medical observation and evaluation for suspected diseases and conditions

313

1124

1.43

7.48

1.3

1.2

13.66

14.16

u/l

0.13

288

1053

IgA nephropathy (IgA glomerulonephritis)

3.96

7.46

1.3

1.2

11.10

10.96

u/l

0.02

Other (not insulin) diabetes medications

471

2091

1.32

7.34

1.3

12.82

14.77

u/l

1.07

428

1931

Other viral diseases, including avohilmo

134

798

1.67

7.31

1.3

12.07

13.98

u/l

0.94

124

742

Cholelithiasis, broad definition with cholecystitis

449

2254

1.33

7.30

1.3

13.23

13.42

u/l

0.05

408

2082

Symptoms and signs concerning food and fluid intake

331

2.06

7.27

1.3

12.67

12.51

u/l

0.03

309

General examination and investigation of persons without complaint and reported diagnosis

306

1120

1.42

7.23

1.3

1.2

21.07

14.19

u/l

0.66

280

1049

Chronic pancreatitis

429

1.93

7.21

1.3

19.87

13.93

u/l

0.52

400

Other infectious diseases, including avohilmo

294

2.13

7.16

1.4

1.3

20.96

13.21

u/l

0.98

271

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

301

2.11

7.13

1.3

11.11

13.35

u/l

0.60

270

Periodontitis

489

2389

1.31

7.05

1.3

13.61

14.46

u/l

0.35

456

2190

Essential (haemorrhagic) thrombocythaemia

3.65

7.04

1.1

1.3

12.05

9.57

u/l

0.39

Accidents

368

1347

1.37

7.02

1.3

12.61

14.14

u/l

0.53

336

1254

Sequelae of cerebrovascular disease

259

1548

1.43

7.01

1.3

11.20

14.55

u/l

2.02

236

1438

Chronic periodontitis, including avohilmo

488

2391

1.30

6.95

1.3

13.64

14.45

u/l

0.33

455

2192

Poisoning by drugs, medicaments and biological substances

456

1.87

6.92

1.2

1.3

16.77

13.04

u/l

0.89

428

Candidiasis

374

1.96

6.84

1.3

12.55

11.87

u/l

0.17

341

Other skin changes

126

762

1.66

6.81

1.3

9.97

15.10

u/l

1.70

117

692

Other necrotizing vasculopathies

242

2.21

6.76

1.3

12.60

10.77

u/l

0.56

222

Asthma, hospital admissions , main diagnosis only

382

2493

1.33

6.74

1.3

12.80

14.57

u/l

0.70

343

2306

Dysphagia

154

981

1.58

6.74

1.2

1.3

10.37

12.91

u/l

2.14

146

909

Use of rivastigmine

810

0.40

6.73

1.2

1.3

24.93

12.85

u/l

0.48

726

Thyrotoxicosis

115

681

1.70

6.72

1.4

1.3

10.59

14.88

u/l

1.12

101

629

Zoster [herpes zoster]

116

689

1.69

6.72

1.3

11.10

14.51

u/l

0.82

105

632

Intracranial injury

303

2052

1.38

6.66

1.3

14.65

14.21

u/l

0.11

270

1908

Barrett oesophagus

169

2.46

6.61

1.3

12.77

12.95

u/l

0.02

154

291

1892

1.39

6.61

1.3

12.53

13.48

u/l

0.31

270

1733

Concussion

218

1154

1.47

6.61

1.3

15.94

15.03

u/l

0.17

194

1079

Colon adenocarcinoma

319

2.02

6.50

1.2

1.3

10.52

11.51

u/l

0.37

283

Sequelae of external causes of morbidity and mortality

146

927

1.58

6.50

1.4

1.3

11.60

14.79

u/l

0.95

131

849

ILD-related respiratory insufficiency

135

2.64

6.50

1.2

1.3

11.67

13.27

u/l

0.28

122

Alcohol dependence

151

968

1.57

6.45

1.3

16.92

14.54

u/l

0.34

142

896

Angina pectoris

304

1466

1.38

6.37

1.4

1.3

17.15

14.52

u/l

0.21

272

1373

Vascular diseases of the intestine

148

2.53

6.37

1.2

22.83

12.27

u/l

0.43

140

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

513

1.77

6.36

1.3

16.24

13.44

u/l

0.65

478

Biguanides

463

2157

1.30

6.35

1.3

13.67

14.58

u/l

0.34

423

1988

Diabetic retinopathy

216

918

1.47

6.27

1.3

11.73

13.03

u/l

0.25

190

846

Asthma, including avohilmo

561

2442

1.27

6.26

1.3

13.90

14.47

u/l

0.18

509

2257

Diaphragmatic hernia

209

1444

1.45

6.24

1.3

13.28

13.75

u/l

0.12

193

1327

malignant neoplasm of male genital organs, including Hilmo

156

600

1.57

6.16

1.3

14.68

13.52

u/l

0.17

141

555

malignant neoplasm of male genital organs

155

597

1.57

6.15

1.3

14.66

13.54

u/l

0.16

140

552

Diabetic maculopathy, excluding more controls

326

1.98

6.15

1.5

1.3

9.36

13.66

u/l

1.70

302

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

480

2410

1.28

5.98

1.3

14.41

14.39

u/l

0.01

431

2235

Leisure time condition

539

1.73

5.94

1.3

19.88

12.58

u/l

0.76

496

Myocardial infarction, without ST-elevation

287

1905

1.36

5.91

1.3

11.65

14.25

u/l

0.80

248

1765

Hydronephrosis

352

1.91

5.90

1.3

13.63

12.08

u/l

0.32

326

Other functional intestinal disorders

242

1573

1.40

5.89

1.2

1.3

15.23

13.46

u/l

0.37

208

1463

Actinic keratosis

274

1824

1.37

5.85

1.3

12.56

13.52

u/l

0.29

256

1670

Pyogenic arthritis

218

2.17

5.81

1.2

1.3

9.93

13.37

u/l

0.83

199

Malignant neoplasm of prostate

154

590

1.55

5.81

1.3

14.68

13.50

u/l

0.17

139

545

Other diseases of intestine

566

1.70

5.79

1.2

1.3

12.42

11.73

u/l

0.23

521

Open wound of ankle and foot

266

2.04

5.71

1.2

1.3

12.11

13.23

u/l

0.26

245

External causes of morbidity and mortality

275

998

1.38

5.65

1.3

13.43

14.57

u/l

0.26

254

939

Chronic diseases of tonsils and adenoids

162

1509

0.68

5.65

1.2

1.3

24.57

13.91

u/l

0.55

152

1390

Skin changes due to chronic exposure to nonionizing radiation

276

1842

1.36

5.64

1.3

12.55

13.50

u/l

0.29

258

1687

Other antidepressants

512

2069

1.26

5.63

1.3

14.86

14.33

u/l

0.14

474

1906

Other nutritional deficiencies

273

1834

1.36

5.63

1.3

14.27

14.94

u/l

0.13

250

1698

Congenital malformations of the circulatory system

306

1.94

5.62

1.5

1.3

9.11

12.65

u/l

1.87

282

Unstable angina pectoris

234

1317

1.40

5.58

1.3

12.28

14.40

u/l

0.59

206

1234

Delirium, not induced by alcohol and other psychoactive substances

579

1.68

5.56

1.1

1.3

12.64

11.97

u/l

0.14

525

Benign neoplasm: Ascending colon

558

1.70

5.55

1.5

1.3

9.52

12.48

u/l

1.65

514

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

455

1.76

5.54

1.3

13.05

13.68

u/l

0.16

420

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

377

1.84

5.51

1.5

1.3

10.09

12.68

u/l

1.19

349

Malignant neoplasm of prostate, including Hilmo

154

596

1.53

5.51

1.3

14.65

13.53

u/l

0.16

139

551

Disorders of other endocrine glands

192

1317

1.44

5.51

1.2

1.3

13.91

13.66

u/l

0.05

169

1208

Injury, poisoning and certain other consequences of external causes

228

805

1.42

5.50

1.3

12.32

14.89

u/l

0.99

210

754

Thyrotoxicosis, other and/or unspecified

514

1.72

5.50

1.4

1.3

10.42

14.94

u/l

0.86

476

Other necrotizing vasculopathies (FG)

191

2.22

5.48

1.3

1.4

12.59

9.99

u/l

0.98

175

Benzodiazepine use

479

2563

1.26

5.47

1.3

14.55

14.20

u/l

0.09

440

2361

Gastrointestinal diseases

201

694

1.45

5.46

1.3

12.45

13.92

u/l

0.59

185

648

Abdominal and pelvic pain

458

1804

1.28

5.43

1.3

17.54

14.16

u/l

0.49

422

1679

Spondyloarthritis

526

1.70

5.34

1.2

1.3

21.91

13.07

u/l

0.91

485

Other noninfective gastroenteritis and colitis

117

741

1.58

5.33

1.3

19.07

13.95

u/l

0.47

104

684

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

353

1.85

5.32

1.5

1.3

10.10

12.87

u/l

1.20

326

Other other unspecified disorders of the circulatory system

113

2.60

5.32

1.2

7.38

13.25

u/l

2.11

102

Other viral diseases, not elsewhere classified

422

1.78

5.28

1.3

13.12

13.22

u/l

0.02

390

Suicide or other Intentional self-harm

528

1.69

5.27

1.3

16.40

12.88

u/l

0.85

491

Cholelithiasis

416

2225

1.28

5.27

1.3

12.06

13.35

u/l

0.80

380

2055

Persons encountering health services for examination and investigation

301

1124

1.35

5.24

1.3

1.2

13.97

14.16

u/l

0.04

276

1053

Cardiomyopathy in other diseases

7.66

5.21

1.5

1.4

4.82

10.93

u/l

2.06

Genitourinary diseases

247

895

1.39

5.19

1.3

13.49

15.81

u/l

0.85

227

847

Chronic periodontitis, complicated

290

2130

1.33

5.18

1.3

13.98

14.64

u/l

0.22

268

1967

Other symptoms and signs involving the digestive system and abdomen

442

1.75

5.14

1.4

1.3

16.90

11.79

u/l

0.49

412

Sub-endpoint used in defining T1D endpoints

142

935

1.50

5.06

1.3

9.89

13.63

u/l

3.08

119

860

Unspecific neurodegenerative disorder

182

1756

0.71

5.01

1.2

1.3

21.13

12.72

u/l

1.66

166

1618

Symptoms and signs involving the skin and subcutaneous tissue

340

2484

1.29

5.00

1.3

12.59

14.45

u/l

1.03

318

2285

Acute pancreatitis

111

707

1.58

4.99

1.3

1.2

17.44

13.45

u/l

0.40

656

Other neurological diseases

395

2409

1.27

4.99

1.3

14.20

13.75

u/l

0.11

356

2227

Any prescribed medicine buy

+∞

4.98

1.3

0.0

8.83

—

u/l

—

Alzheimer disease, including avohilmo

162

1609

0.69

4.96

1.2

1.3

21.70

12.93

u/l

1.53

144

1476

Multiple myeloma and malignant plasma cell neoplasms

180

2.19

4.95

1.5

1.3

10.81

12.07

u/l

0.24

167

Diabetic retinopathy, strict definition

537

1.63

4.94

1.3

8.39

13.38

u/l

4.62

502

Unknown and unspecified causes of morbidity

180

2.18

4.93

1.3

10.30

13.58

u/l

0.63

168

Dizziness and giddiness

371

2255

1.28

4.93

1.3

12.14

14.04

u/l

1.30

339

2095

Sequelae with surgical and medical care as external cause

114

733

1.56

4.93

1.4

1.3

11.37

14.69

u/l

0.77

104

671

Examination and observation for other reasons

265

1107

1.35

4.92

1.2

15.35

14.26

u/l

0.23

247

1039

Decubitus ulcer and pressure area

255

1.98

4.88

1.2

1.3

10.49

14.24

u/l

1.04

232

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

563

1.64

4.87

1.3

16.24

13.00

u/l

0.80

522

Inflammatory diseases of the central nervous system

201

2.10

4.85

1.0

1.3

10.52

12.30

u/l

0.51

187

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

269

1.94

4.85

1.2

1.3

20.19

13.22

u/l

1.11

250

Fracture of lower leg, including ankle

251

1839

1.34

4.83

1.3

14.16

14.67

u/l

0.10

230

1703

Chronic gastritis

160

1109

1.45

4.82

1.3

1.2

15.00

14.68

u/l

0.04

147

1025

Noninfective enteritis and colitis

203

1465

1.39

4.82

1.3

20.21

14.47

u/l

0.62

181

1356

Childhood asthma (age<16)

10.05

4.77

1.2

1.0

9.67

6.14

u/l

—

Poisoning by medicine

401

1.75

4.74

1.2

1.3

18.14

12.96

u/l

1.10

374

Other viral diseases, not elsewhere classified, including avohilmo

564

1.62

4.72

1.3

1.2

12.14

13.50

u/l

0.42

524

Other systemic involvement of connective tissue (FG)

129

844

1.50

4.72

1.2

1.3

13.89

11.98

u/l

0.81

117

779

Acute upper respiratory infections of multiple and unspecified sites

334

1889

1.29

4.70

1.3

12.77

14.74

u/l

1.01

305

1742

Other and unspecified immunodeficiencies with predominantly antibody defects

7.27

4.67

2.0

1.2

13.10

12.64

u/l

—

Use of other anti-dementia drugs

115

1393

0.66

4.63

1.3

24.04

13.23

u/l

1.22

1275

Use of memantine

115

1393

0.66

4.63

1.3

24.04

13.23

u/l

1.22

1275

Degeneration of macula and posterior pole

314

1876

1.29

4.55

1.3

11.94

14.15

u/l

1.16

288

1736

DVT of lower extremities

109

713

1.54

4.41

1.2

1.3

13.01

15.54

u/l

0.47

654

Malignant neoplasm of rectum

244

1.94

4.38

1.4

1.3

15.98

11.21

u/l

0.39

217

Sequelae of injuries, of poisoning and of other consequences of external causes

104

675

1.55

4.36

1.3

13.52

13.55

u/l

0.01

626

Fracture of foot, except ankle

596

1.58

4.36

1.3

13.91

13.96

u/l

0.01

555

Paracetamol or NSAID medication

230

1.72

4.35

1.2

1.3

12.31

12.61

u/l

0.03

212

Retinal vascular disorders

504

1.64

4.34

1.3

10.53

13.17

u/l

1.19

455

Other symptoms and signs involving cognitive functions and awareness

279

1903

1.30

4.33

1.3

13.81

14.11

u/l

0.08

248

1775

Superficial injury of head

119

796

1.50

4.31

1.2

1.3

18.22

14.65

u/l

0.35

104

737

Adenocarcinoma and papilloma adenocarcinoma of rectum

239

1.93

4.28

1.3

10.85

11.48

u/l

0.12

212

Gastro-oesophageal reflux disease

313

2068

1.28

4.21

1.3

13.43

14.65

u/l

0.30

289

1911

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

213

1.98

4.20

1.4

1.3

9.84

11.89

u/l

0.61

200

Obesity due to excess calories

180

1308

1.38

4.20

1.4

1.3

12.52

14.87

u/l

0.89

168

1218

Corns and callosities

186

2.06

4.19

1.2

1.3

13.84

11.33

u/l

0.50

169

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

248

1.90

4.19

1.3

10.66

11.76

u/l

0.24

221

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

140

975

1.44

4.17

1.3

11.19

14.30

u/l

1.11

126

903

Triptan medication for migraine, single purchase ok

132

1286

0.69

4.15

1.3

1.2

23.22

13.75

u/l

0.42

124

1188

Migraine, single triptan purchase ok & required. ICD-code if available is included

132

1286

0.69

4.15

1.3

1.2

23.22

13.75

u/l

0.42

124

1188

Other infectious diseases

250

1.89

4.11

1.4

1.3

21.10

13.66

u/l

0.74

232

Degeneration of the brain due to alcohol

2.60

4.08

1.2

1.3

21.14

12.56

u/l

0.52

Benign neoplasm: Sigmoid colon

114

767

1.49

4.08

1.4

1.3

9.56

14.22

u/l

1.55

108

696

Other reaction to severe stress, and adjustment disorders

106

701

1.51

4.07

1.3

1.2

11.46

15.51

u/l

1.06

100

647

Other and unspecified nonorganic psychotic disorders

345

1.74

4.07

1.3

1.2

15.67

13.15

u/l

0.58

324

Retinal vascular occlusion

498

1.62

4.05

1.3

10.62

12.84

u/l

0.95

450

Diseases of pulp and periapical tissues, including avohilmo

487

2066

1.22

4.04

1.3

14.24

14.01

u/l

0.06

456

1890

Cholecystitis

538

1.59

4.01

1.3

18.40

13.01

u/l

0.49

495

Smoking dependency

217

1.95

4.00

1.2

1.3

12.29

12.37

u/l

0.02

197

Obesity, other/unspecified

119

811

1.47

3.98

1.4

1.3

13.05

15.28

u/l

0.45

110

748

Hypoparathyroidism

2.55

3.97

1.3

1.2

11.64

11.18

u/l

0.07

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.04

3.97

1.3

1.2

14.94

10.81

u/l

0.46

Transient ischemic attack

309

1940

1.27

3.96

1.3

13.95

13.99

u/l

0.01

275

1806

Mental and behavioural disorders due to tobacco

218

1.94

3.96

1.2

1.3

12.29

12.24

u/l

0.01

199

Malignant neoplasm of rectum, including Hilmo

304

1.78

3.95

1.3

15.02

11.53

u/l

0.32

272

Other condition

372

1.70

3.91

1.3

11.30

13.51

u/l

0.70

346

Disorders of parathyroid gland

108

718

1.49

3.87

1.2

1.3

11.62

13.96

u/l

0.46

652

Other and unspecified drugs and medicaments

213

1.94

3.86

1.4

1.2

8.75

11.72

u/l

1.43

195

Acute pancreatitis (for exclusion)

111

752

1.48

3.86

1.3

17.44

13.38

u/l

0.40

693

Exclusions for E4_PCOS_CONSORTIUM

219

1028

1.33

3.84

1.2

18.64

12.32

u/l

0.45

197

946

Missing teeth due to accident, extraction or parodontitis

325

2317

1.25

3.81

1.3

14.30

13.84

u/l

0.16

301

2131

Obesity

243

1763

1.30

3.81

1.4

1.3

12.82

15.31

u/l

1.15

224

1635

Aortic aneurysm

164

1172

1.38

3.80

1.3

10.91

14.43

u/l

3.27

153

1097

Dentofacial anomalies [including malocclusion]

131

1447

0.71

3.79

1.3

13.45

14.89

u/l

0.41

123

1339

Selective deficiency of immunoglobulin G [IgG] subclasses

8.95

3.79

1.6

1.1

7.57

11.63

u/l

—

Diseases of the musculoskeletal system and connective tissue

206

767

1.35

3.79

1.3

1.2

13.43

14.73

u/l

0.40

190

715

Congenital malformations, deformations and chromosomal abnormalities

197

1399

1.34

3.78

1.4

1.3

10.14

15.53

u/l

3.86

180

1296

Other systemic involvement of connective tissue

133

938

1.42

3.75

1.2

1.3

14.03

13.86

u/l

0.03

120

863

Degeneration of nervous system due to alcohol

2.48

3.74

1.2

1.3

21.14

12.57

u/l

0.52

Specific personality disorders

400

1.65

3.73

1.3

1.2

13.03

13.12

u/l

0.02

370

Other disorders of ear

436

2316

1.22

3.72

1.3

16.37

13.95

u/l

0.31

393

2150

Noninfectious colitis NAS

370

1.68

3.72

1.4

1.3

25.07

11.86

u/l

0.82

344

Soft tissue disorders

449

1889

1.22

3.71

1.3

15.28

14.28

u/l

0.11

407

1755

Superficial injury of hip and thigh

526

1.56

3.68

1.3

13.00

12.81

u/l

0.04

478

Personality disorders, excluding more controls

431

1.62

3.68

1.2

1.3

19.19

13.99

u/l

0.38

398

Injury of unspecified body region

211

1.91

3.62

1.4

1.3

12.15

12.25

u/l

0.02

192

Obesity and other hyperalimentation

243

1775

1.29

3.60

1.4

1.3

12.82

15.29

u/l

1.14

224

1647

Benign neoplasm: Rectum, anus and anal canal

120

838

1.44

3.60

1.3

12.00

14.80

u/l

0.49

113

763

Dermatitis and eczema

510

2525

1.20

3.60

1.3

13.42

14.47

u/l

0.52

473

2322

Psoriasis

129

913

1.42

3.58

1.2

1.3

14.23

14.77

u/l

0.09

115

848

Vitreous haemorrhage

329

1.71

3.58

1.3

11.23

13.20

u/l

0.49

300

Bronchitis, not specified as acute or chronic

219

1.88

3.58

1.3

10.42

12.11

u/l

0.52

207

Conductive and sensorineural hearing loss

408

2224

1.22

3.56

1.3

17.01

13.55

u/l

0.45

367

2065

Psoriasis vulgaris

579

1.53

3.55

1.3

14.91

13.47

u/l

0.29

539

Ulcer of oesophagus

258

1.80

3.47

1.3

1.2

14.27

12.69

u/l

0.22

234

Osteoporosis with pathological fracture (FG)

237

1.83

3.43

1.4

1.2

9.97

9.65

u/l

0.08

214

Diseases of the eye and adnexa

288

1140

1.27

3.41

1.3

12.91

15.09

u/l

1.11

267

1062

Injuries to unspecified part of trunk, limb or body region

289

1.74

3.40

1.3

11.00

11.98

u/l

0.23

262

Focal epilepsy

102

701

1.46

3.34

1.2

1.3

11.46

12.69

u/l

0.57

639

Procreative management

495

1.50

3.30

1.3

1.2

21.65

12.77

u/l

0.54

458

Dementia

195

1734

0.77

3.30

1.2

1.3

19.67

12.89

u/l

1.30

175

1598

Low back pain

347

1909

1.23

3.30

1.3

13.28

13.97

u/l

0.27

318

1760

Collagenous colitis

255

1.77

3.29

1.2

1.3

12.35

11.15

u/l

0.29

234

Hypercalcemia

142

2.06

3.27

1.2

22.62

12.50

u/l

0.97

127

Benign neoplasm: Rectum

106

738

1.44

3.27

1.3

11.71

14.99

u/l

0.51

671

Other renal tubulo-interstitial diseases

3.05

3.26

1.1

1.3

9.08

10.71

u/l

0.44

Urinary track infection

157

575

1.37

3.24

1.3

1.2

11.60

12.01

u/l

0.13

139

526

Weight loss

339

1.66

3.24

1.3

12.96

12.91

u/l

0.01

306

Sensorineural hearing loss

398

2198

1.21

3.22

1.3

17.16

13.52

u/l

0.46

356

2041

Disorders of plasma-protein metabolism, not elsewhere classified

6.50

3.20

1.1

1.3

7.86

8.36

u/l

—

Sleep apnoea

435

2293

1.20

3.16

1.3

13.67

14.69

u/l

0.39

406

2110

Neurological diseases, wide definition

255

1.56

3.16

1.2

12.54

13.59

u/l

0.28

242

Alzheimer disease

152

1451

0.75

3.15

1.2

1.3

21.87

13.00

u/l

1.39

134

1327

Other and unspecified vascular occlusions

381

1.61

3.14

1.3

11.75

13.24

u/l

0.41

340

Infective dermatitis

351

1.63

3.10

1.2

1.3

16.19

13.89

u/l

0.31

321

Other diseases of pancreas

275

1.72

3.10

1.4

1.3

46.35

11.72

u/l

0.51

255

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

445

1.55

3.09

1.3

11.09

12.63

u/l

0.41

406

Injuries to the knee and lower leg

530

2439

1.18

3.07

1.3

13.43

14.52

u/l

0.46

481

2255

Hepatomegaly and splenomegaly, not elsewhere classified

5.08

3.06

1.0

1.5

13.88

9.62

u/l

—

Alcohol abuse, main dg, excluding more controls

407

1.58

3.05

1.1

1.3

15.66

13.46

u/l

0.39

375

Inguinal hernia

310

1675

1.23

3.05

1.3

14.69

14.98

u/l

0.06

291

1557

Fracture of shoulder and upper arm

173

1318

1.31

3.05

1.2

1.3

14.74

14.08

u/l

0.08

156

1211

Use of donepezil

1110

0.68

3.04

1.3

17.90

14.07

u/l

0.58

1003

Dementia in Alzheimer disease

905

0.66

3.04

1.3

17.72

11.72

u/l

0.52

826

Haemophagocytic lymphohistiocytosis

10.88

3.04

1.2

35.40

10.40

u/l

—

Focal epilepsy, strict definition

667

1.44

3.01

1.2

1.3

11.63

12.68

u/l

0.43

609

Emotionally unstable personality disorder

126

2.07

3.01

1.3

13.77

13.03

u/l

0.09

117

Pain (limb, back, neck, head abdominally)

333

1362

1.23

3.01

1.3

14.26

14.34

u/l

0.02

304

1272

Intestinal helminthiases, other/unspecified, including avohilmo

10.41

3.01

1.6

1.0

9.20

19.60

u/l

—

Status post-ami

165

946

1.33

3.00

1.3

10.01

14.47

u/l

5.40

150

884

Coeliac disease

285

1.69

3.00

1.4

1.3

10.51

12.11

u/l

0.59

264

Mitochondrial myopathy

10.27

3.00

1.4

1.0

6.80

14.80

u/l

—

152

1065

1.34

2.99

1.3

12.48

14.01

u/l

0.33

136

967

Respiratory tuberculosis, not confirmed, including avohilmo

162

1.93

2.95

1.3

1.2

25.54

14.93

u/l

0.98

148

Dementia, including avohilmo

213

1839

0.79

2.95

1.2

1.3

19.51

12.75

u/l

1.47

193

1696

Mycoses, including avohilmo

398

2538

1.19

2.95

1.3

14.42

14.43

u/l

0.00

369

2333

Any mental disorder

492

2091

1.18

2.94

1.3

15.40

14.18

u/l

0.31

458

1936

Dental operations

328

1380

1.22

2.93

1.3

13.77

13.74

u/l

0.01

302

1277

Disorders of adult personality and behaviour

499

1.51

2.93

1.2

18.76

13.55

u/l

0.43

463

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

219

1575

1.27

2.93

1.4

1.3

10.34

16.00

u/l

4.68

200

1459

Exclusions for E4_PCOS_BROAD

419

1.55

2.93

1.2

1.3

15.17

12.28

u/l

0.45

388

Pustulosis palmaris et plantaris

2.33

2.91

1.0

1.3

12.36

10.86

u/l

0.26

Other metabolic disorders

265

1.70

2.91

1.4

1.2

8.56

17.35

u/l

0.96

248

Zoster [herpes zoster], including avohilmo

258

2010

1.24

2.88

1.3

11.42

14.21

u/l

1.97

238

1849

Contact with and exposure to communicable diseases

427

1.54

2.87

1.2

1.3

12.76

14.07

u/l

0.25

398

Epilepsy

148

1112

1.33

2.87

1.2

1.3

11.64

15.19

u/l

1.48

136

1041

Carbimazole or st.post thyroidectomy, condition for graves disease

494

1.50

2.86

1.4

1.3

11.25

14.77

u/l

0.56

453

Panic disorder

193

1.82

2.83

1.2

1.3

14.07

12.28

u/l

0.42

178

Other and unspecified disorders of vitreous body

122

1606

0.74

2.79

1.3

13.54

14.19

u/l

0.17

114

1481

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

8.64

2.77

1.2

9.40

8.17

u/l

—

Injuries to the elbow and forearm

288

2022

1.22

2.77

1.2

1.3

14.93

14.19

u/l

0.14

255

1868

Alzheimer’s disease (Late onset)

107

1209

0.73

2.76

1.2

1.3

23.96

13.06

u/l

1.21

1104

Other and unspecified nonscarring hair loss

8.44

2.76

1.6

1.0

6.00

12.67

u/l

—

Conotruncal defects

8.40

2.75

1.2

1.3

13.60

13.83

u/l

—

Malignant neoplasm of stomach, including Hilmo

145

1.94

2.74

1.2

11.96

9.62

u/l

0.58

126

Alzheimer’s disease, strict definition

115

1259

0.73

2.74

1.2

1.3

23.29

12.98

u/l

1.24

102

1151

Systemic sclerosis,strict definition

5.08

2.74

1.0

1.1

10.29

13.71

u/l

—

Benign neoplasm: Connective and other soft tissue of thorax

6.17

2.72

1.0

1.3

9.50

12.00

u/l

—

Nonalcoholic fatty liver disease

218

1.75

2.71

1.5

1.3

10.56

11.52

u/l

0.36

198

Pustular psoriasis

2.16

2.71

1.0

1.3

12.19

10.80

u/l

0.28

Dermatophytosis

493

1.49

2.70

1.4

1.3

12.44

13.16

u/l

0.18

454

Diabetic maculopathy

389

1.54

2.69

1.4

1.3

9.36

12.48

u/l

1.53

361

Myeloid leukaemia

2.20

2.68

1.3

11.55

13.52

u/l

0.29

Shoulder lesions

360

1804

1.20

2.67

1.2

1.3

13.44

14.01

u/l

0.25

324

1676

Respiratory tuberculosis, not confirmed

161

1.88

2.67

1.3

1.2

26.00

15.01

u/l

0.98

147

Statin medication

236

1063

1.25

2.67

1.3

12.37

16.77

u/l

1.57

216

988

Schizophrenia or delusion, excluding more controls

103

735

1.39

2.63

1.3

15.03

14.86

u/l

0.03

671

Other and specified injuries of hip and thigh

2.48

2.63

1.3

1.2

10.67

10.83

u/l

0.03

Caries of enamel

272

2161

0.82

2.59

1.2

1.3

15.32

14.69

u/l

0.13

263

1976

Sequelae of injuries of upper limb

229

1.71

2.59

1.4

1.3

14.97

11.11

u/l

0.50

211

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

7.46

2.58

1.8

1.3

9.20

10.86

u/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

531

1.45

2.57

1.3

11.45

12.50

u/l

0.27

488

Other crystal arthropathies

2.38

2.57

1.3

7.81

10.03

u/l

0.61

Agoraphobia

4.02

2.57

1.4

1.1

15.75

11.75

u/l

—

Implicit parasitic Sepsis

5.59

2.56

1.7

1.3

10.67

8.91

u/l

—

Spondylopathies

378

1886

1.19

2.55

1.3

18.29

13.72

u/l

0.57

348

1738

Insomnia

249

2117

0.82

2.55

1.3

13.85

14.76

u/l

0.27

229

1944

Hyperparathyroidism

625

1.41

2.54

1.2

1.3

11.29

14.61

u/l

0.60

568

Achalasia of cardia

2.53

2.54

1.5

1.3

10.21

11.55

u/l

0.17

Other hearing loss

180

1374

1.27

2.54

1.3

13.24

13.03

u/l

0.06

159

1269

Sulfonylureas

227

1456

1.24

2.54

1.3

11.60

14.33

u/l

0.93

201

1346

Gonarthrosis, primary, with knee surgery

226

2165

0.81

2.52

1.3

18.25

13.47

u/l

0.35

214

1991

Sleep disorders

266

2221

0.82

2.52

1.3

13.51

14.79

u/l

0.44

245

2041

Personality disorders

476

1.47

2.52

1.2

19.19

13.79

u/l

0.39

441

Right hemicolectomy

224

1.71

2.51

1.1

1.3

11.47

13.68

u/l

0.41

207

Malignant neoplasm of stomach

129

1.95

2.50

1.2

11.48

9.92

u/l

0.32

113

Focal epilepsy, mode (most common among epilepsy diagnosis)

618

1.41

2.49

1.2

1.3

11.38

12.67

u/l

0.52

567

Other diseases of biliary tract

286

1.62

2.48

1.3

1.2

9.80

13.16

u/l

1.08

266

Benign neoplasm: Colon, unspecified

143

1100

1.30

2.46

1.4

1.3

11.23

15.22

u/l

1.61

128

1010

Alcohol abuse, main dg

430

1.49

2.45

1.1

1.3

15.66

14.53

u/l

0.16

398

207

1430

1.25

2.44

1.3

12.13

13.68

u/l

0.48

188

1311

Hypertensive encephalopathy

5.17

2.43

1.5

1.2

7.83

12.42

u/l

—

Chronic laryngitis and laryngotracheitis

464

1.47

2.42

1.4

1.3

12.02

13.37

u/l

0.40

427

Other diseases of anus and rectum

155

1203

1.29

2.42

1.3

11.69

12.70

u/l

0.42

137

1119

Mixed connective tissue disease

2.92

2.42

1.7

1.1

14.82

12.48

u/l

0.20

Implicit parasitic Sepsis, including avohilmo

5.10

2.41

1.7

1.3

10.67

9.83

u/l

—

Degenerative diseases of the nervous system

175

1585

0.79

2.41

1.2

1.3

20.56

12.97

u/l

1.38

157

1454

Retinal detachments and breaks

192

1538

1.25

2.39

1.3

13.60

14.77

u/l

0.18

176

1423

Benign thyroid growths and nodules

139

993

1.30

2.38

1.3

11.16

14.00

u/l

0.99

127

905

Other mosquito-borne viral fevers, including avohilmo

6.34

2.38

1.0

1.1

8.60

8.50

u/l

—

Other chondrocalcinosis

2.54

2.37

1.1

1.2

8.23

11.36

u/l

0.70

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

384

2554

1.17

2.35

1.3

13.14

14.58

u/l

0.68

353

2353

Arthropathies

363

1552

1.18

2.35

1.3

13.45

13.79

u/l

0.11

333

1437

Papulosquamous disorders

169

1338

1.27

2.33

1.2

1.3

14.96

14.49

u/l

0.10

148

1245

Schizophrenia, schizotypal and delusional disorders

104

771

1.35

2.32

1.3

15.00

15.46

u/l

0.07

715

Disorders of eyelid, lacrimal system and orbit

400

2516

1.17

2.30

1.3

11.57

14.26

u/l

2.42

371

2320

Schizophrenia or delusion

103

764

1.35

2.30

1.3

15.03

15.52

u/l

0.07

708

Injuries to the ankle and foot

255

1801

1.21

2.30

1.3

19.51

14.55

u/l

0.38

224

1669

Maze procedure for atrial fibrillation

4.75

2.29

1.3

1.2

6.33

8.23

u/l

—

Insulin, fast-acting (human)

316

1.55

2.29

1.3

9.18

14.12

u/l

1.84

292

Crystal arthropathies, rheuma endpoint

2.25

2.29

1.3

7.81

10.44

u/l

0.76

Drug-induced polyneuropathy

3.54

2.28

1.3

1.2

14.88

9.39

u/l

—

Psychiatric diseases

437

1888

1.16

2.24

1.3

13.66

14.31

u/l

0.18

407

1750

Myositis ossificans

5.76

2.23

1.8

1.2

8.40

9.44

u/l

—

Heterophoria

157

1.79

2.21

1.2

1.3

69.00

11.66

u/l

0.48

143

Myalgia

642

1.37

2.20

1.3

1.2

11.68

13.53

u/l

0.94

595

Faecal incontinence

257

1.60

2.17

1.3

12.03

11.86

u/l

0.03

240

Exposure to other specified factors

319

2325

1.18

2.17

1.3

20.55

13.67

u/l

0.81

304

2127

Other and unspecified effects of external causes

628

1.37

2.14

1.3

1.2

14.52

13.20

u/l

0.31

579

Benign neoplasm: Skin of trunk

109

1.94

2.10

1.4

1.2

9.62

11.21

u/l

0.51

5.11

2.08

1.4

1.1

13.00

13.90

u/l

—

Dental pulpitis, including avohilmo

241

1850

0.83

2.07

1.2

1.3

14.57

15.38

u/l

0.25

226

1702

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

220

1753

1.21

2.07

1.4

1.3

12.18

14.12

u/l

1.54

206

1618

Traumatic subdural haemorrhage

631

1.35

2.06

1.4

1.3

12.43

14.67

u/l

0.41

589

Disorders of ocular muscles, binocular movement, accommodation and refraction

164

1304

1.25

2.06

1.3

22.46

13.76

u/l

0.46

145

1209

Other diseases of liver

523

1.40

2.05

1.4

1.3

10.16

13.18

u/l

1.82

485

Acute generalized exanthematous pustulosis

103

1.95

2.05

1.6

1.2

9.25

12.13

u/l

0.74

Fall on and from stairs and steps

112

858

1.31

2.05

1.4

1.3

18.15

14.56

u/l

0.34

106

787

Budesonide

309

1.52

2.05

1.4

1.3

10.71

12.69

u/l

0.74

292

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.03

2.04

1.2

17.67

10.67

u/l

—

Coxarthrosis [arthrosis of hip](FG)

281

1631

1.19

2.04

1.3

17.15

13.34

u/l

0.34

265

1513

Behavioural syndromes associated with physiological disturbances and physical factors

286

2279

0.85

2.03

1.3

13.32

14.65

u/l

0.50

265

2095

Mental disorders, not otherwise specified

125

1.85

2.02

1.1

1.3

14.41

11.30

u/l

0.51

115

Infections with a predominantly sexual mode of transmission

474

1.41

2.00

1.2

14.83

13.10

u/l

0.45

439

Acute sinusitis

175

1289

1.23

2.00

1.3

1.2

19.66

15.01

u/l

0.45

160

1191

Symptoms and signs involving the nervous and musculoskeletal systems

262

2211

1.19

1.99

1.3

14.04

14.08

u/l

0.01

235

2039

Erectile dysfunction, exclusion

4.67

1.96

1.4

1.2

6.20

10.09

u/l

—

Erythema multiforme

2.37

1.95

1.8

1.2

11.08

11.87

u/l

0.08

Other and unspecified medical devices associated with adverse incidents

4.63

1.95

1.0

1.2

14.80

13.45

u/l

—

ILD and respiratory illness in diseases classified elsewhere

4.63

1.95

1.4

1.1

13.00

13.55

u/l

—

Melanocytic naevi of ear and external auricular canal

3.82

1.95

1.5

1.2

11.17

10.56

u/l

—

Unspecified threat to breathing

4.59

1.94

1.4

1.0

8.80

11.73

u/l

—

Caries of dentine, including avohilmo

379

1676

1.16

1.93

1.3

12.87

13.61

u/l

0.25

352

1542

Fibroblastic disorders

127

999

1.27

1.92

1.4

1.3

13.02

14.71

u/l

0.57

119

926

Other disorders of veins

168

1342

1.23

1.92

1.2

1.3

15.32

14.53

u/l

0.16

158

1236

Malignant neoplasm of pancreas, including Hilmo

211

1.62

1.91

1.2

18.03

10.68

u/l

0.92

183

Other specified/unspecified hearing loss

315

1.50

1.90

1.2

1.3

15.81

12.13

u/l

0.58

290

Viral warts

204

1.62

1.88

1.3

9.77

12.21

u/l

0.72

188

Assault by sharp object

3.20

1.88

1.0

1.1

16.71

10.86

u/l

—

Benign paroxysmal vertigo

1092

0.75

1.87

1.5

1.3

11.88

13.94

u/l

0.56

993

Other abnormal uterine and vaginal bleeding

417

1.36

1.85

1.3

1.2

11.30

15.31

u/l

0.53

381

Iridocyclitis

689

1.32

1.84

1.3

13.71

15.19

u/l

0.23

635

Other strabismus

482

1.39

1.83

1.2

1.3

37.07

12.11

u/l

0.57

449

Abdominal aortic aneurysm (AAA)

540

1.36

1.82

1.2

1.3

10.01

15.10

u/l

2.47

499

Polycystic ovarian syndrome, consortium definition

184

865

1.22

1.80

1.3

1.2

11.74

13.64

u/l

0.48

163

787

Acute and subacute iridocyclitis

554

1.36

1.80

1.2

1.3

14.19

13.40

u/l

0.15

514

Schizophrenia

344

1.46

1.79

1.2

1.3

14.26

13.10

u/l

0.30

321

Oral lichen planus, including avohilmo , including avohilmo

168

0.42

1.78

1.7

1.3

10.14

10.44

u/l

—

149

Pneumoconiosis due to dust containing silica

3.44

1.76

1.0

1.2

15.00

10.28

u/l

—

Presbycusis

720

1.31

1.76

1.3

12.83

13.21

u/l

0.08

658

Alzheimer’s disease (Late onset), excluding more controls

586

0.73

1.75

1.2

1.3

30.53

14.63

u/l

1.07

544

Complications of internal orthopaedic prosthetic devices, implants and grafts

116

915

1.27

1.75

1.3

11.92

14.58

u/l

0.68

104

837

Hyperplasia of prostate

223

1053

1.19

1.74

1.4

1.3

15.35

14.58

u/l

0.13

210

983

Acute alcohol intoxication, ICD10

609

1.33

1.74

1.2

1.3

15.27

13.85

u/l

0.28

564

Nerve, nerve root and plexus disorders

474

2526

1.13

1.73

1.3

12.74

14.48

u/l

1.12

428

2336

Hypothyroidism, strict autoimmune

293

1653

1.16

1.73

1.3

13.16

14.03

u/l

0.20

277

1525

Melanocytic naevi

111

873

1.27

1.71

1.3

19.35

14.69

u/l

0.30

103

805

Eustachian salpingitis and obstruction

103

1.85

1.71

1.4

1.2

15.47

12.10

u/l

0.53

Use of antiglaucoma preparations and miotics

315

1.47

1.71

1.3

18.07

12.47

u/l

0.59

286

Generalized skin eruption due to drugs and medicaments

1.92

1.70

1.7

1.2

9.94

12.47

u/l

0.52

Fracture of skull and facial bones

655

1.32

1.70

1.2

1.3

15.28

13.25

u/l

0.53

608

Anterior Iridocyclitis

595

1.33

1.69

1.3

14.10

13.35

u/l

0.15

552

Any dementia, excluding more controls

176

1454

0.83

1.67

1.2

1.3

18.51

13.23

u/l

0.81

156

1345

Malignant neoplasm of pancreas

172

1.63

1.67

1.2

1.3

19.09

10.51

u/l

0.86

150

Melanoma in situ of upper limb, including shoulder

3.20

1.67

1.3

1.2

11.17

13.05

u/l

—

Other blood glucose lowering drugs, excl. Insulins

640

1.32

1.66

1.4

1.3

11.99

15.07

u/l

0.60

587

Dorsalgia

415

1940

1.13

1.65

1.3

13.05

14.04

u/l

0.50

381

1789

Strabismus

683

1.30

1.64

1.2

1.3

31.50

12.91

u/l

0.57

630

Acute upper respiratory infections

464

2475

1.12

1.64

1.3

13.54

14.17

u/l

0.21

423

2285

Viral and other specified intestinal infections

367

1.41

1.63

1.3

13.16

13.07

u/l

0.01

345

Other diseases of urinary system

443

2207

1.13

1.63

1.3

17.24

13.56

u/l

0.54

405

2042

Dental caries, including avohilmo

361

1618

1.14

1.62

1.3

13.10

13.64

u/l

0.16

334

1486

Retinal detachment with retinal break

479

1.36

1.62

1.2

1.3

18.71

12.97

u/l

0.38

436

Suggestive for eosinophilic asthma

262

1.49

1.60

1.2

1.3

15.18

12.07

u/l

0.84

244

Disorders of continuity of bone

214

1.55

1.59

1.5

1.3

13.00

12.49

u/l

0.09

199

Acute myeloid leukaemia, including Hilmo

2.72

1.58

1.3

1.2

14.00

10.19

u/l

—

Acute myeloid leukaemia, helper endpoint

2.72

1.58

1.3

1.2

14.00

10.19

u/l

—

Acute myeloid leukaemia

2.72

1.58

1.3

1.2

14.00

10.19

u/l

—

Any dementia

200

1634

0.84

1.57

1.2

1.3

18.56

13.02

u/l

1.03

179

1506

Use of galantamine

386

0.62

1.56

1.3

11.96

12.71

u/l

0.10

348

Fissure and fistula of anal and rectal regions

744

1.28

1.55

1.3

14.61

13.14

u/l

0.25

690

Viral and other specified intestinal infections, including avohilmo

514

1.33

1.54

1.3

12.77

13.04

u/l

0.05

483

Mantle cell lymphoma, including Hilmo

2.45

1.54

1.3

1.2

9.87

10.61

u/l

—

Thiamine deficiency

3.39

1.53

1.4

1.3

7.00

7.60

u/l

—

Carcinoma in situ of other and unspecified genital organs

2.61

1.51

1.4

1.1

14.14

16.48

u/l

—

Acute alcohol intoxication

116

934

1.24

1.51

1.2

1.3

15.15

14.55

u/l

0.12

108

861

Diseases of pulp and periapical tissues and dental caries

323

1448

1.14

1.51

1.3

12.17

13.46

u/l

0.47

300

1325

Psychotic depression

144

0.42

1.51

1.2

1.3

16.50

11.08

u/l

—

134

Disorders of skin appendages

166

1381

1.20

1.49

1.3

16.40

15.12

u/l

0.11

154

1273

Congenital malformations of the respiratory system, including avohilmo

2.45

1.48

1.8

1.1

10.89

11.78

u/l

—

Other disorders of bone

444

1.35

1.47

1.3

14.70

12.98

u/l

0.33

415

Deep bite

150

0.47

1.47

1.1

1.3

20.88

11.84

u/l

—

135

Other mental disorders due to brain damage and dysfunction and to physical disease

505

1.33

1.47

1.3

19.45

11.65

u/l

0.72

459

Cholecystectomy

317

2367

1.14

1.47

1.3

11.96

14.06

u/l

1.18

285

2187

Injuries to the shoulder and upper arm

379

2598

1.13

1.46

1.3

13.85

14.27

u/l

0.10

349

2389

Juvenile arthritis (FINNGEN)

2.23

1.46

1.5

1.1

17.00

10.74

u/l

—

Burns and corrosions of multiple body regions

3.15

1.44

1.0

1.1

15.00

11.19

u/l

—

Migraine

886

0.79

1.44

1.3

12.52

14.40

u/l

0.46

829

Other encephalitis

2.05

1.44

1.0

1.2

6.14

12.02

u/l

—

Diabetic neuropathy

470

1.34

1.43

1.2

1.3

11.39

13.48

u/l

0.57

430

Encephalitis

1.98

1.43

1.0

1.2

7.38

12.28

u/l

—

Disorders of eyelid in diseases classified elsewhere

1.98

1.43

1.2

1.3

8.54

12.45

u/l

1.33

Malignant neoplasm of tonsil and base of tongue

2.32

1.43

1.0

1.3

22.33

10.06

u/l

—

Conjunctivitis (acute, non atopic)

741

1.26

1.43

1.4

1.2

16.47

15.58

u/l

0.07

684

Unspecified chronic bronchitis

110

1.74

1.43

1.6

1.3

11.00

12.66

u/l

0.29

102

Covid-19 suspected case

430

1.35

1.42

1.3

17.79

12.18

u/l

0.92

400

Superficial injury of lower leg

701

1.27

1.41

1.3

10.74

15.05

u/l

1.15

645

severe traumatic brain injury, does not include concussion

124

1015

1.22

1.41

1.3

12.62

13.95

u/l

0.54

115

929

Disorders of sclera, cornea, iris and ciliary body

219

1886

1.16

1.41

1.3

13.95

15.04

u/l

0.29

196

1744

Sleep apnoea, including avohilmo

428

2319

1.12

1.40

1.3

13.81

14.66

u/l

0.31

399

2130

Urolithiasis

117

1428

0.82

1.38

1.4

1.3

12.89

14.37

u/l

0.48

112

1324

Female genital prolapse

425

0.74

1.38

1.2

10.12

15.14

u/l

0.75

386

Perforation of tympanic membrane

272

1.44

1.37

1.3

12.26

11.64

u/l

0.14

247

Rheumatoid lung disease

3.00

1.37

1.4

1.2

39.00

11.47

u/l

—

Unspecified mental disorder

127

1046

1.21

1.36

1.2

1.3

15.76

14.31

u/l

0.28

113

970

Disorders of refraction and accommodation

623

1.28

1.36

1.3

11.83

13.23

u/l

0.38

581

Endometriosis of pelvic peritoneum

249

0.58

1.35

1.3

1.2

21.12

18.42

u/l

0.15

227

Colectomy operation

653

1.27

1.35

1.2

1.3

10.81

12.34

u/l

0.67

600

Mature T/NK-cell lymphomas, hilmo

2.16

1.34

1.0

1.2

26.33

11.16

u/l

—

Gingivitis and periodontal diseases

448

2082

1.11

1.34

1.3

15.57

13.72

u/l

0.62

412

1907

Vertigo of central origin

2.06

1.33

1.2

1.1

11.73

11.63

u/l

0.01

Fracture of forearm

207

1601

1.16

1.33

1.2

1.3

12.56

13.75

u/l

0.32

178

1476

Adverse effects, not elsewhere classified

418

1.34

1.33

1.3

13.18

12.19

u/l

0.20

387

Other anxiety disorders

119

830

1.22

1.32

1.2

1.3

13.62

15.76

u/l

0.44

109

769

Spinal stenosis

271

1753

1.14

1.31

1.3

17.90

13.31

u/l

0.40

247

1618

Calculus of kidney and ureter

104

1275

0.81

1.30

1.5

1.3

11.80

14.09

u/l

1.19

1178

Postprocedural endocrine and metabolic disorders, not elsewhere classified

242

1.45

1.29

1.4

1.2

8.90

11.47

u/l

1.67

226

Varicose veins

284

1892

1.13

1.28

1.3

12.79

14.21

u/l

0.61

256

1753

Postprocedural disorders of digestive system, not elsewhere classified

1.73

1.27

1.3

13.12

12.24

u/l

0.11

Diseases of oral cavity, salivary glands and jaws

293

1331

1.13

1.26

1.3

12.45

14.05

u/l

0.50

264

1208

Diseases of external ear

151

1276

1.18

1.26

1.3

15.63

14.78

u/l

0.10

141

1175

Postmenopausal osteoporosis with pathological fracture

178

1.52

1.26

1.3

1.2

9.15

10.01

u/l

0.20

157

Superficial injury of abdomen, lower back and pelvis

431

1.32

1.26

1.4

1.3

25.51

13.47

u/l

0.75

398

Disorders of lacrimal system

179

1511

1.17

1.24

1.2

1.3

10.97

14.37

u/l

2.03

159

1386

Campylobacter enteritis

1.91

1.23

1.3

1.2

16.00

10.74

u/l

0.47

Soft tissue disorders related to use, overuse and pressure

118

978

1.21

1.22

1.3

1.2

14.05

13.57

u/l

0.04

108

908

Diseases of inner ear

194

2139

0.87

1.21

1.3

12.16

14.20

u/l

1.04

180

1969

Presence of other devices

132

1089

1.19

1.21

1.4

1.3

11.83

13.36

u/l

0.65

119

1010

Umbilical hernia

116

961

1.21

1.2

1.3

16.57

14.29

u/l

0.39

105

894

Superficial injury of ankle and foot

229

1.44

1.21

1.5

1.3

54.76

13.52

u/l

0.50

210

Injury of muscle and tendon at shoulder and upper arm level

123

1470

0.84

1.21

1.3

13.66

14.79

u/l

0.27

113

1361

Neurological diseases

324

1449

1.12

1.19

1.3

13.29

14.72

u/l

0.38

296

1342

Female infertility, cervical, vaginal, other or unspecified origin

285

0.69

1.19

1.1

1.2

12.77

17.45

u/l

0.40

260

Disease of hard tissues of teeth, NOS

200

1208

0.87

1.19

1.3

15.19

14.20

u/l

0.15

186

1092

Nonorganic sleeping disorders, excluding more controls

435

1.31

1.19

1.4

1.3

9.46

12.84

u/l

2.19

399

Other juvenile arthritis

2.11

1.18

1.6

1.1

18.63

10.75

u/l

—

Impingement syndrome of shoulder

101

828

1.22

1.18

1.2

10.43

13.98

u/l

2.63

771

Primary gonarthrosis, bilateral

214

2046

0.87

1.17

1.3

20.39

13.49

u/l

0.51

200

1880

Coxarthrosis

250

1420

1.14

1.17

1.3

17.87

13.29

u/l

0.37

236

1316

Contraceptive management

502

0.76

1.17

1.2

13.90

14.62

u/l

0.18

465

Ventral hernia

107

886

1.21

1.14

1.3

12.94

14.84

u/l

0.39

816

Benign lipomatous neoplasm

1023

0.81

1.13

1.2

1.3

12.06

14.43

u/l

0.68

938

Polyarthrosis

684

1.23

1.12

1.3

13.93

11.95

u/l

0.67

629

Gluteal tendinitis

114

0.44

1.12

1.0

1.2

25.40

10.57

u/l

—

104

Carcinoma in situ of skin of ear and external auricular canal

1.72

1.12

1.2

1.3

12.40

12.61

u/l

0.02

Other vitreous opacities

119

1.60

1.11

1.3

1.2

11.89

12.49

u/l

0.08

110

All dysplastic lesions of the cervix uteri

263

1.39

1.11

1.2

9.71

12.95

u/l

1.71

243

Erectile dysfunction

406

1.31

1.11

1.2

1.3

11.51

13.11

u/l

0.39

379

Leiomyoma of uterus

169

814

1.16

1.10

1.3

1.2

19.83

11.70

u/l

0.44

150

741

Tuberculosis of other organs

1.83

1.09

1.4

1.2

14.50

14.47

u/l

0.00

Other meningitis

2.39

1.09

1.0

1.1

12.20

12.57

u/l

—

Abnormal serum enzyme levels

174

1456

1.15

1.09

1.3

12.40

14.40

u/l

0.98

154

1355

Neuromuscular dysfunction of bladder

321

1.34

1.07

1.1

1.3

14.94

13.19

u/l

0.28

294

Hernia of abdominal wall

206

1812

1.14

1.06

1.2

1.3

15.10

14.51

u/l

0.12

187

1674

Benign neoplasm of other and ill-defined parts of digestive system

631

1.24

1.06

1.2

1.3

11.20

14.81

u/l

0.73

578

Benign neoplasm of eye and adnexa

331

1.33

1.05

1.1

1.3

10.82

11.36

u/l

0.14

303

Atopic dermatitis

124

1162

0.85

1.04

1.3

1.2

13.50

15.74

u/l

0.66

119

1078

Kela-code for severe mental illness

114

961

1.19

1.03

1.2

1.3

15.76

14.56

u/l

0.21

102

889

Benign neoplasm: Kidney

106

1.61

1.03

1.5

1.2

15.53

11.07

u/l

0.43

Urticaria and erythema

112

943

1.19

1.02

1.3

14.32

14.39

u/l

0.01

104

870

Fenamates

370

0.75

1.01

1.6

1.3

11.67

12.71

u/l

0.19

330

Disorders of the thyroid gland

398

2357

1.10

1.00

1.3

12.69

14.39

u/l

0.64

368

2169

Myocardial infarction, unclassifiable

139

1067

1.17

1.00

1.2

1.3

12.02

13.36

u/l

0.33

123

977

Myasthenia gravis

1.85

0.99

1.3

1.2

13.22

11.26

u/l

—

Atopic dermatitis, strict definition with reimbursement

483

1.25

0.97

1.3

15.14

12.87

u/l

0.68

453

Other disorders of lacrimal gland

141

1217

1.16

0.97

1.2

1.3

10.55

14.18

u/l

1.81

128

1113

Polymyalgia rheumatica

540

1.24

0.96

1.1

1.3

14.69

14.86

u/l

0.02

489

Granulomatous disorders of skin and subcutaneous tissue

1.86

0.96

1.6

1.1

18.90

12.63

u/l

—

Endometriosis ASRM stages 1,2

247

0.65

0.95

1.3

1.2

21.13

11.19

u/l

1.55

227

Disorders of synovium and tendon

160

1552

0.87

0.95

1.4

1.2

14.20

14.12

u/l

0.02

142

1434

Contusion of other and unspecified parts of foot

1.69

0.95

1.3

1.2

8.92

11.59

u/l

0.87

Mental retardation, excluding more controls

1.78

0.95

1.1

1.3

10.67

10.72

u/l

—

Inguinal of femoral hernia, unilateral

1.66

0.94

1.1

1.2

16.21

11.29

u/l

0.77

Femoral hernia, unilateral

1.66

0.94

1.1

1.2

16.21

11.29

u/l

0.77

Inguinal hernia, unilateral

1.66

0.94

1.1

1.2

16.21

11.29

u/l

0.77

Herpesviral [herpes simplex] infections, including avohilmo

560

1.23

0.94

1.2

1.3

20.19

15.32

u/l

0.53

517

Dermatographic urticaria

118

0.51

0.94

1.2

12.67

11.89

u/l

—

108

Lower back pain or/and sciatica

449

2571

1.09

0.93

1.3

13.12

14.41

u/l

0.64

413

2367

Synovial cyst of popliteal space [Baker]

217

1.39

0.93

1.3

65.40

10.71

u/l

0.50

199

Hyperfunction of pituitary gland

1.72

0.92

1.2

13.50

13.06

u/l

0.06

Disorders of vestibular function (Vertigo)

166

1838

0.88

0.92

1.3

12.23

13.99

u/l

0.73

155

1690

Benign neoplasm: Small intestine

142

1.49

0.92

1.1

1.2

11.75

11.96

u/l

0.03

129

Other disorders of the musculoskeletal system and connective tissue

472

1.25

0.92

1.2

1.3

15.15

13.00

u/l

0.40

433

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

111

946

1.17

0.91

1.3

14.07

16.29

u/l

0.38

103

883

Glucagon-like peptide-1 (GLP-1) analogues

111

946

1.17

0.91

1.3

14.07

16.29

u/l

0.38

103

883

Rotator cuff syndrome

281

1748

1.11

0.91

1.2

1.3

14.06

14.01

u/l

0.02

248

1621

Myocardial infarction, with ST-elevation

102

864

1.18

0.91

1.3

11.21

13.92

u/l

1.02

789

Pregnancy, childbirth and the puerperium

408

0.81

0.91

1.3

1.2

9.41

15.50

u/l

0.91

363

Allergic conjunctivitis

123

1370

0.86

0.89

1.3

1.2

15.15

14.07

u/l

0.26

117

1254

Infections with a predominantly sexual mode of transmission, including avohilmo

573

1.21

0.89

1.3

1.2

14.43

13.41

u/l

0.27

532

Anxiety (asthma-related co-morbidities)

165

1101

1.14

0.89

1.2

1.3

13.71

15.71

u/l

0.51

149

1023

Disorders of conjunctiva

252

2160

0.90

0.88

1.3

15.00

14.78

u/l

0.04

231

1983

Localized swelling, mass and lump of skin and subcutaneous tissue

127

1101

1.15

0.86

1.2

1.3

13.51

14.75

u/l

0.25

121

1017

Pedestrian injured in transport accident

180

0.61

0.86

1.5

1.3

32.64

11.47

u/l

0.60

165

Paralytic ileus

128

1.49

0.86

1.3

34.00

10.98

u/l

0.65

116

Tuberculosis of other organs, strict

1.63

0.85

1.4

1.2

14.54

14.71

u/l

0.01

Tuberculosis of other organs, strict, including avohilmo

1.63

0.85

1.4

1.2

14.54

14.71

u/l

0.01

Other and unspecified nail disorders

1.75

0.82

1.3

1.2

10.50

12.90

u/l

—

Other disorders of Eustachian tube

1.70

0.82

1.5

1.2

10.27

11.73

u/l

0.21

Alzheimer’s disease (Atypical or mixed), excluding more controls

433

0.79

0.82

1.2

1.3

21.77

15.51

u/l

0.29

401

Prurigo nodularis

1.65

0.82

1.2

15.00

10.82

u/l

0.55

Idiopathic thrombocytopenic purpura

1.61

0.81

1.2

1.3

14.00

10.96

u/l

0.42

Injuries involving multiple body regions

1.61

0.81

1.5

1.2

20.77

10.63

u/l

0.33

Chondropathies

346

1.27

0.81

1.4

1.3

16.18

12.42

u/l

0.65

319

Other/unspecified dorsalgia

146

1269

1.14

0.81

1.3

1.2

14.40

13.64

u/l

0.18

136

1169

Follow-up examination after treatment for conditions other than malignant neoplasms

160

941

1.13

0.80

1.3

1.2

14.83

14.05

u/l

0.10

151

879

Noninflammatory disorders of female genital tract

446

0.83

0.80

1.3

1.2

11.40

15.44

u/l

0.59

406

Allergic urticaria

164

1.40

0.79

1.3

1.2

16.09

12.88

u/l

0.40

150

Acute nasopharyngitis (common cold)

214

1.35

0.78

1.3

1.2

9.63

14.25

u/l

2.41

197

Benign neoplasm of urinary organs

156

1.41

0.78

1.4

1.2

14.59

12.70

u/l

0.19

142

Corneal ulcer

501

1.22

0.78

1.2

1.3

11.61

13.49

u/l

0.42

464

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

120

1315

0.87

0.77

1.3

1.2

14.97

14.19

u/l

0.17

114

1202

Other disorders of eyelid

221

1886

1.11

0.77

1.2

1.3

11.68

14.09

u/l

1.21

205

1734

All anxiety disorders

166

1145

1.12

0.77

1.2

1.3

13.77

15.76

u/l

0.52

150

1058

Conjunctivitis (acute, non atopic), including avohilmo

361

2356

0.92

0.76

1.3

14.23

u/l

0.00

333

2162

Endometriosis

437

0.82

0.76

1.3

1.2

15.91

15.36

u/l

0.05

398

Gonarthrosis,primary

376

2446

0.93

0.76

1.3

16.68

13.84

u/l

0.33

349

2252

Persistent mood disorders

530

1.21

0.76

1.3

13.54

14.88

u/l

0.17

487

Other diseases of hard tissues of teeth

275

1299

1.10

0.76

1.3

13.62

14.04

u/l

0.08

258

1179

Other surgical follow-up care

1.70

0.76

1.3

1.2

13.30

10.21

u/l

—

Headache

196

1361

1.11

0.75

1.3

1.2

12.99

13.82

u/l

0.29

177

1267

Lichen sclerosus et atrophicus

279

0.72

0.75

1.8

1.2

10.40

16.53

u/l

0.56

252

Benign neoplasm: Skin of lower limb, including hip

1.65

0.75

1.7

1.2

8.55

12.81

u/l

1.75

Follow-up care involving plastic surgery

1.65

0.75

1.2

1.3

9.00

9.30

u/l

0.07

Benign neoplasm: Lip

1.67

0.74

1.0

1.2

10.22

12.55

u/l

—

Xerosis cutis

1.64

0.73

1.2

10.67

11.30

u/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.04

0.73

1.0

1.3

38.80

12.79

u/l

—

Keratitis

129

1136

1.14

0.73

1.3

13.92

14.49

u/l

0.09

117

1051

Fracture at wrist and hand level

119

1039

1.14

0.73

1.3

13.86

15.87

u/l

0.38

105

958

Haemorrhoids and perianal venous thrombosis

151

1334

1.12

0.73

1.3

22.49

13.23

u/l

0.45

135

1242

Nystagmus and other irregular eye movements

2.01

0.73

1.2

9.60

10.36

u/l

—

Other specific arthropathies, wide

1.80

0.72

1.1

16.00

9.38

u/l

—

Other and unspecified iridocyclitis

106

0.56

0.72

1.2

18.00

10.89

u/l

—

Delivery, wide proxy

454

0.84

0.72

1.2

9.77

15.85

u/l

1.06

406

Disorders of muscles

290

1.28

0.72

1.4

1.3

15.53

14.02

u/l

0.20

268

Nontoxic diffuse goitre

1.62

0.71

1.5

1.1

9.27

10.43

u/l

0.35

Other enthesopathies

103

895

1.15

0.71

1.4

1.2

13.26

13.59

u/l

0.08

830

Malignant neoplasm of ureter, including Hilmo

1.94

0.71

1.2

8.60

11.14

u/l

—

Nonorganic sleeping disorders

471

1.21

0.70

1.4

1.3

9.46

12.34

u/l

1.80

435

Thyrotoxicosis with diffuse goitre

318

1.26

0.70

1.4

1.3

9.82

11.50

u/l

0.65

293

Conjunctivitis

209

1850

0.91

0.70

1.4

1.3

15.56

14.83

u/l

0.13

195

1697

Acute alcohol intoxication ICD-9

118

1.45

0.69

1.1

1.3

12.88

12.05

u/l

0.11

112

Deforming dorsopathies

860

1.15

0.69

1.3

27.36

12.63

u/l

0.52

798

Alzheimer’s disease (Atypical or mixed)

600

0.82

0.69

1.3

21.33

12.20

u/l

0.52

540

Atrophic disorders of skin

387

0.77

0.69

1.6

1.2

10.47

15.30

u/l

0.61

353

Sleep disorders (combined)

467

2284

1.07

0.68

1.3

13.45

14.60

u/l

0.46

429

2103

Other dorsopathies, not elsewhere classified

401

1940

1.07

0.68

1.3

13.07

14.04

u/l

0.50

364

1789

Gastrojejunal ulcer

1.68

0.68

1.1

1.3

8.57

11.42

u/l

—

Crushed, pushed or stepped on by crowd or human stampede

110

1.46

0.68

1.3

1.2

14.31

12.04

u/l

0.42

102

Other and unspecified glaucoma

266

1.28

0.68

1.3

22.19

10.26

u/l

0.69

247

Gestational diabetes (for exclusion)

220

0.75

0.67

1.3

1.2

15.08

13.88

u/l

0.17

206

Fall on same level involving ice and snow

225

2057

1.09

0.66

1.3

12.74

14.33

u/l

0.76

197

1902

Diseases of the ear and mastoid process

455

2136

1.07

0.66

1.3

17.18

14.05

u/l

0.44

417

1978

Other disorders of urethra and urinary system

302

1943

1.08

0.66

1.3

19.16

13.39

u/l

0.60

273

1800

Other bursopathies

430

1.21

0.65

1.3

1.2

43.93

13.09

u/l

0.50

398

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.54

0.65

1.4

1.3

10.42

13.51

u/l

0.50

Macular hole

206

1.31

0.65

1.1

1.2

13.82

12.14

u/l

0.30

185

Symptoms and signs involving speech and voice

136

1215

1.12

0.64

1.4

1.3

13.04

14.57

u/l

0.45

126

1113

Other joint disorders

321

1552

1.08

0.64

1.3

13.78

13.79

u/l

0.00

291

1437

Ulcerative colitis

681

1.16

0.63

1.3

12.45

12.99

u/l

0.16

633

Dermatophytosis, including avohilmo

254

2296

1.08

0.62

1.3

15.58

14.46

u/l

0.28

237

2114

Mood disorders

346

2369

0.93

0.62

1.2

1.3

15.05

14.45

u/l

0.15

323

2170

Periapical abscess

166

1503

1.11

0.62

1.3

13.60

15.64

u/l

0.66

156

1393

Disturbances of smell and taste

102

0.59

0.62

1.2

7.17

10.19

u/l

—

Diseases of male genital organs

244

1130

1.09

0.60

1.4

1.3

14.95

14.96

u/l

0.00

227

1055

Episodal and paroxysmal disorders

434

2068

1.06

0.60

1.3

14.90

14.62

u/l

0.07

385

1911

Functional dyspepsia

797

1.14

0.60

1.3

1.2

12.20

14.37

u/l

0.50

740

Mood [affective] disorders

345

2362

0.93

0.60

1.2

1.3

15.06

14.48

u/l

0.15

322

2164

All dysplastic lesions of the cervix uteri, vagina or vulva

344

1.22

0.59

1.1

1.2

10.61

12.08

u/l

0.44

316

Chronic myeloproliferative disease

1.55

0.59

1.1

1.2

11.75

11.00

u/l

—

Combinations of oral blood glucose lowering drugs

129

1156

1.12

0.59

1.3

10.88

15.48

u/l

2.26

119

1067

Benign neoplasm of brain and other parts of central nervous system

174

0.69

0.59

1.0

1.3

15.42

11.98

u/l

0.21

159

Hypothyroidism, other/unspecified

353

2171

1.07

0.58

1.3

12.64

14.35

u/l

0.56

326

1998

Arthrosis

296

1507

1.08

0.58

1.3

13.59

13.49

u/l

0.03

272

1395

Blepharochalasis

130

1168

1.11

0.58

1.2

1.3

11.42

13.97

u/l

0.77

119

1066

Macular cyst

116

0.60

0.57

1.3

1.2

13.00

13.07

u/l

—

104

Acetic acid derivatives and related substances

136

631

1.11

0.56

1.3

15.66

14.23

u/l

0.23

126

572

Alzheimer disease, excluding more controls

634

0.88

0.56

1.2

1.3

25.74

14.44

u/l

0.91

591

Spontaneous abortion

556

0.87

0.56

1.1

1.2

14.31

14.74

u/l

0.04

512

Other inflammation of eyelid

421

1.19

0.55

1.2

1.3

12.33

15.88

u/l

0.45

385

Dementia due to Parkinson's disease

123

0.65

0.55

1.3

1.2

9.13

13.45

u/l

—

111

Hallux valgus (acquired)

796

0.89

0.54

1.3

1.2

13.08

12.16

u/l

0.25

731

Chronic sinusitis

148

1345

1.10

0.53

1.4

1.3

14.54

14.06

u/l

0.07

141

1240

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

758

1.13

0.53

1.3

13.69

13.70

u/l

0.00

699

Ganglion

513

0.84

0.53

1.5

1.3

16.18

12.92

u/l

0.57

477

Carcinoma in situ of skin, other sites/unspecified

1.52

0.53

1.2

13.50

11.70

u/l

—

Oxicams

620

0.89

0.52

1.2

1.3

12.69

13.92

u/l

0.27

562

Cervical polyps

215

0.74

0.52

1.3

1.2

8.75

19.10

u/l

0.83

195

Complications following abortion and ectopic and molar pregnancy

1.43

0.52

1.6

1.3

9.33

12.08

u/l

—

Colonic or urogenital fistula

883

1.12

0.52

1.3

14.34

14.65

u/l

0.04

814

Carcinoma in situ of colon

100

1.41

0.52

1.3

29.93

11.78

u/l

0.55

Other and unspecified urticaria

424

1.18

0.52

1.2

1.3

16.16

11.61

u/l

0.98

394

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.50

0.51

1.2

1.1

32.50

12.35

u/l

—

Redundant prepuce, phimosis and paraphimosis

758

1.13

0.51

1.4

1.2

15.67

15.26

u/l

0.06

707

Propionic acid derivatives

113

633

0.90

0.50

1.3

13.47

14.25

u/l

0.14

107

574

Coxibs

133

631

1.11

0.50

1.3

13.21

14.23

u/l

0.22

124

572

Sciatica+with lumbago

171

1644

0.92

0.50

1.3

12.03

13.94

u/l

1.09

155

1511

Non-selective monoamine reuptake inhibitors

149

1307

1.09

0.49

1.3

16.96

14.30

u/l

0.37

138

1192

Neuralgia and neuritis, unspecified

127

1.34

0.49

1.2

1.3

12.65

9.49

u/l

0.70

115

Intracerebral haemorrhage

566

1.15

0.49

1.2

1.3

9.33

13.48

u/l

2.74

523

Cervicobrachial syndrome

627

0.86

0.49

1.3

1.2

10.73

12.99

u/l

1.04

586

Nontraumatic intracranial haemmorrhage

877

1.12

0.49

1.3

11.01

15.49

u/l

1.44

809

Lagophthalmos

1.56

0.49

1.1

1.3

6.57

11.10

u/l

—

Open wound of shoulder and upper arm

1.56

0.49

1.1

1.2

15.29

11.08

u/l

—

Total colectomy operation

108

0.65

0.48

1.0

1.2

17.57

11.49

u/l

—

Total colectomy

108

0.65

0.48

1.0

1.2

17.57

11.49

u/l

—

Nonsuppurative otitis media

386

1.17

0.48

1.2

1.3

13.10

14.39

u/l

0.26

356

Nontoxic single thyroid nodule

189

0.74

0.48

1.4

1.3

9.00

10.78

u/l

0.54

174

Crohn's disease of large intestine

1.41

0.47

1.2

10.75

10.71

u/l

0.01

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.46

0.47

1.3

1.1

19.14

8.74

u/l

—

Disorders of vitreous body

190

1946

0.93

0.46

1.3

12.87

14.18

u/l

0.53

175

1789

Pedal cyclist injured in noncollision transport accidents

255

0.78

0.46

1.3

34.05

12.34

u/l

0.54

235

Lichen planus

386

0.83

0.46

1.2

1.3

17.69

15.17

u/l

0.22

355

Other intervertebral disc disorders

340

1915

1.06

0.45

1.3

13.47

13.87

u/l

0.14

301

1766

Single delivery by forceps and vacuum extractor

0.69

0.45

1.1

1.3

13.56

13.27

u/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

590

0.88

0.44

1.3

1.2

11.00

14.96

u/l

0.78

540

Injuries to the neck

619

1.13

0.44

1.3

15.41

13.09

u/l

0.33

571

Spondylolisthesis/Spondylolysis

572

1.14

0.44

1.3

1.2

33.60

13.49

u/l

0.43

536

Disorders of breast

115

920

1.10

0.44

1.2

12.10

13.29

u/l

0.27

106

832

Inflammatory bowel disease

895

1.11

0.43

1.3

20.27

13.17

u/l

0.44

827

Hypothyreosis and Thyroxine purchase for inclusion criteria

363

2255

1.05

0.43

1.3

12.44

14.24

u/l

0.63

336

2071

Femoral hernia

148

1.29

0.43

1.3

13.63

12.49

u/l

0.15

135

Viral haemorrhagic fevers, not elsewhere classified/unspecified

202

1.24

0.43

1.2

1.3

15.40

12.01

u/l

0.37

185

Other symptoms and signs involving the nervous and musculoskeletal systems

153

1413

1.08

0.43

1.3

15.20

14.69

u/l

0.06

135

1306

Dorsopathies

403

1941

1.05

0.42

1.3

13.56

14.04

u/l

0.22

365

1790

Gonarthrosis [arthrosis of knee](FG)

316

1719

1.06

0.42

1.3

18.22

13.34

u/l

0.52

291

1593

Non-allergic asthma

230

1.22

0.42

1.2

1.3

10.39

11.78

u/l

0.41

211

Bipolar affective disorders

350

1.17

0.42

1.1

1.3

20.36

12.60

u/l

0.97

322

Lateral epicondylitis

304

1.19

0.41

1.3

15.13

13.13

u/l

0.31

286

Colon adenocarcinoma, helper endpoint

566

1.13

0.41

1.2

1.3

10.52

12.26

u/l

0.78

514

Adrenogenital disorders

0.00

0.41

0.0

1.2

—

9.60

—

Disorders of other and unspecified cranial nerves

0.00

0.41

0.0

1.3

—

9.67

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.41

0.0

1.3

—

10.13

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.41

0.0

1.4

—

13.62

—

Other congenital malformations of upper alimentary tract

0.00

0.41

0.0

1.2

—

12.44

—

Premature separation of placenta [abruptio placentae]

0.00

0.41

0.0

1.3

—

11.56

—

Other acquired deformities of musculoskeletal system and connective tissue

105

1.34

0.41

1.3

14.57

11.30

u/l

0.81

Adenocarcinoma and papillary adenocarcinoma of stomach

1.36

0.41

1.1

1.3

13.87

9.80

u/l

—

Nontoxic multinodular goitre

606

1.12

0.40

1.2

1.3

11.93

14.78

u/l

0.52

551

Tinnitus

793

0.89

0.39

1.3

11.50

13.02

u/l

0.61

737

Cervicocranial syndrome

292

0.82

0.39

1.5

1.3

13.92

11.41

u/l

0.46

271

Prolonged pregnancy

1.33

0.39

1.1

1.2

17.93

13.30

u/l

0.60

Plantar fascial fibromatosis

242

1.20

0.38

1.3

11.88

10.85

u/l

0.30

223

Scar conditions and fibrosis of skin

1.38

0.38

1.2

10.64

11.73

u/l

0.12

Suppurative and unspecified otitis media

647

1.11

0.38

1.3

12.75

13.93

u/l

0.35

596

Arthropod-borne viral fevers and viral haemorrhagic fevers

261

1.19

0.38

1.2

1.3

15.52

12.46

u/l

0.40

239

Cholesteatoma of middle ear

181

0.77

0.38

1.3

13.29

12.40

u/l

0.11

164

Dementia due to Parkinsons disease, excluding more controls

116

0.69

0.37

1.3

1.4

9.13

13.49

u/l

—

109

Other diseases of upper respiratory tract

470

2351

1.04

0.36

1.3

15.40

13.72

u/l

0.22

437

2163

Vasomotor and allergic rhinitis

881

0.91

0.36

1.2

12.30

13.81

u/l

0.37

807

Pedestrian injured in collision with pedal cycle

0.66

0.35

1.6

1.1

12.00

10.37

u/l

—

Poor fetal growth

0.65

0.35

1.4

1.2

9.80

13.93

u/l

—

Other degenerative diseases of the nervous system

133

899

1.08

0.35

1.2

1.3

24.86

13.80

u/l

1.28

123

845

Memory loss

366

1.15

0.35

1.4

1.3

16.38

11.98

u/l

0.72

334

Primary angle-closure glaucoma

144

1.25

0.35

1.2

9.54

10.75

u/l

0.33

132

Enthesopathies of lower limb, excluding foot

670

0.90

0.35

1.5

1.2

13.60

12.85

u/l

0.14

625

Glaucoma

279

2253

1.05

0.35

1.3

15.37

13.58

u/l

0.41

252

2085

Menorrhagia

441

1.10

0.34

1.4

1.2

11.03

15.17

u/l

0.60

401

Excessive attrition of teeth

167

1761

0.94

0.34

1.3

14.06

15.53

u/l

0.41

155

1632

Urticaria

689

1.10

0.34

1.3

15.62

14.96

u/l

0.08

640

Other disorders of eye and adnexa

339

1.15

0.34

1.2

1.3

12.52

11.59

u/l

0.19

313

Lichen ruber planus, wide definition including periferal and oral lichen planus

689

0.90

0.34

1.3

13.02

14.81

u/l

0.29

636

Mixed and other personality disorders

118

1.27

0.33

1.1

1.3

37.33

12.34

u/l

0.44

112

Special screening examination for infectious and parasitic diseases

295

1.14

0.33

1.1

1.2

15.85

16.61

u/l

0.11

278

Other noninflammatory disorders of uterus, except cervix

409

1.11

0.33

1.1

1.2

10.79

15.26

u/l

0.61

371

Organic, including symptomatic, mental disorders

287

1924

1.05

0.33

1.2

1.3

17.31

12.99

u/l

1.13

262

1782

Spirochaetal infections, other/unspecified

253

0.83

0.33

1.2

1.3

13.24

11.97

u/l

0.18

229

Cervical disc disorders

128

1372

0.93

0.32

1.3

1.2

11.53

13.80

u/l

1.25

117

1263

Chronic rhinitis, nasopharyngitis and pharyngitis

102

942

1.08

0.32

1.4

1.3

13.53

13.49

u/l

0.01

865

Benign neoplasm: Stomach

313

1.15

0.32

1.3

10.65

11.40

u/l

0.13

286

Chronic mastoiditis

1.31

0.32

1.2

12.50

13.93

u/l

0.17

Benign neoplasm: Anus and anal canal

1.31

0.31

1.3

1.2

13.42

10.88

u/l

0.34

Seborrhoeic keratosis

107

992

1.08

0.31

1.3

19.15

14.83

u/l

0.25

910

Flat foot [pes planus] (acquired)

258

1.16

0.31

1.2

1.3

16.67

10.79

u/l

1.04

236

Suppurative otitis media, unspecified

1.32

0.31

1.1

1.2

7.29

10.96

u/l

—

Inflammatory diseases of female pelvic organs

126

923

0.93

0.30

1.3

1.2

13.09

13.45

u/l

0.06

114

841

Benign mammary dysplasia

315

0.86

0.30

1.3

1.2

11.45

16.03

u/l

0.43

285

Diplopia

428

1.12

0.30

1.2

1.3

13.83

13.05

u/l

0.12

392

Simple and mucopurulent chronic bronchitis

138

1.23

0.30

1.7

1.3

18.71

12.56

u/l

0.59

130

362

1.13

0.30

1.3

19.86

13.74

u/l

0.23

333

Somatoform disorder

362

1.13

0.30

1.3

12.86

12.04

u/l

0.17

336

Impacted cerumen

438

1.12

0.30

1.6

1.3

10.69

12.49

u/l

0.66

399

Benign neoplasm of other and unspecified sites

1.31

0.30

1.2

20.55

11.68

u/l

0.39

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.29

0.30

1.4

1.3

10.42

12.82

u/l

0.38

Gonarthrosis

273

1473

1.05

0.29

1.3

18.77

13.36

u/l

0.49

250

1364

Nonspecific lymphadenitis

108

0.74

0.29

1.9

1.3

9.25

11.19

u/l

—

Dislocation, sprain and strain of joints and ligaments of knee

159

1521

0.94

0.29

1.2

1.3

13.18

15.37

u/l

0.84

141

1418

Dislocation, sprain and strain of joint and ligaments of hip

110

0.73

0.29

1.1

1.3

10.00

12.71

u/l

—

100

Melanocytic naevi of other and unspecified parts of face

130

1.23

0.28

1.5

1.2

14.81

11.22

u/l

0.57

117

Glucosamine medication

204

1711

0.95

0.28

1.4

1.3

12.85

13.65

u/l

0.15

194

1564

Amenorrhoea

1.29

0.28

1.1

1.2

9.13

12.13

u/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

319

2059

1.04

0.28

1.3

13.02

14.24

u/l

0.33

303

1891

Anxiety disorders, excluding more controls

277

1695

1.04

0.27

1.2

1.3

12.75

14.57

u/l

0.78

253

1560

Voice disturbances

883

1.08

0.27

1.4

1.3

12.51

14.09

u/l

0.37

809

Pterygium

117

0.77

0.27

1.0

1.2

24.00

12.71

u/l

—

105

Injuries to the wrist and hand

366

2514

0.96

0.27

1.3

14.43

14.46

u/l

0.01

334

2318

Bicipital tendinitis

121

0.74

0.27

1.1

1.3

14.33

11.16

u/l

—

110

Viral warts, including avohilmo

499

1.10

0.27

1.3

11.77

12.67

u/l

0.19

462

Other headache syndromes

112

1191

0.94

0.27

1.3

14.61

13.84

u/l

0.14

106

1107

Injury of muscle and tendon at lower leg level

490

0.90

0.27

1.3

13.31

13.74

u/l

0.09

455

Twin gestation

1.21

0.26

1.0

1.3

10.75

12.28

u/l

—

Multiple gestation

1.19

0.26

1.0

1.3

10.75

12.19

u/l

—

Other congenital malformations of skin

0.70

0.26

1.4

1.1

10.20

11.47

u/l

—

Extrapyramidal and movement disorders

157

1655

0.95

0.26

1.3

13.51

14.39

u/l

0.24

143

1522

Diseases of middle ear and mastoid

169

1310

1.05

0.26

1.3

12.47

15.27

u/l

1.18

159

1203

Complications of genitourinary prosthetic devices, implants and grafts

1.25

0.25

1.4

1.3

10.33

15.82

u/l

—

Irregular menses

562

0.92

0.25

1.4

1.2

11.76

15.25

u/l

0.66

519

Other extrapyramidal and movement disorders in other diseases

913

0.93

0.25

1.3

15.55

14.48

u/l

0.16

831

Depression

314

2175

0.96

0.25

1.2

1.3

13.54

14.60

u/l

0.45

293

1992

Ulcerative ileocolitis

1.19

0.24

1.2

17.56

9.85

u/l

—

Acute appendicitis, no complications

152

1590

0.95

0.24

1.3

13.77

15.72

u/l

0.51

146

1467

Intermittent heterotropia

0.74

0.24

1.7

1.2

12.50

12.88

u/l

—

Testicular hypofunction

0.72

0.24

1.2

1.3

20.83

10.22

u/l

—

Presbyopia

161

1.18

0.24

1.4

1.3

9.00

11.01

u/l

0.70

151

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

620

1.08

0.23

1.3

1.2

11.70

14.81

u/l

0.61

574

Lesion of ulnar nerve

427

1.10

0.23

1.4

1.3

13.50

14.06

u/l

0.10

399

Other diseases of lip and oral mucosa

141

1339

1.05

0.23

1.2

1.3

17.64

13.82

u/l

1.15

131

1237

Polyuria

103

969

1.06

0.23

1.4

1.3

13.36

15.25

u/l

0.41

889

Anti-inflammatory and antirheumatic products, non-steroids

133

633

1.06

0.23

1.3

13.14

14.25

u/l

0.20

122

574

Benign neoplasm: Skin of ear and external auricular canal

134

1.20

0.23

1.3

1.2

9.56

13.16

u/l

0.53

123

Other diseases of gallbladder

134

1.20

0.23

1.6

1.2

8.81

11.81

u/l

0.72

126

Speech therapy

907

0.94

0.22

1.5

1.2

13.67

14.69

u/l

0.15

828

Restless leg syndrome

410

0.90

0.22

1.3

14.53

11.27

u/l

0.60

377

Other fall from one level to another

689

1.07

0.22

1.4

1.3

15.54

13.59

u/l

0.23

639

Disorders of vitreous body and globe

202

1988

0.96

0.22

1.3

12.68

14.21

u/l

0.68

185

1828

Visual field defects

286

1.12

0.21

1.3

17.48

13.49

u/l

0.24

260

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.4

—

11.60

—

conjunctival haemorrhage

267

1.12

0.21

1.4

1.3

9.71

11.89

u/l

0.79

240

Injury of blood vessels at lower leg level

0.00

0.21

0.0

1.1

—

11.20

—

Acute inflammation of orbit

0.00

0.21

0.0

1.2

—

10.55

—

Drug-induced obesity

0.00

0.21

0.0

1.2

—

12.00

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.1

—

8.50

—

Other sudden death, cause unknown

0.00

0.21

0.0

1.3

—

8.92

—

LSIL lesion of the vagina

0.00

0.21

0.0

1.1

—

15.25

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.1

—

13.31

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.2

—

10.23

—

Supervision of normal pregnancy

1.16

0.21

1.3

1.2

10.60

14.18

u/l

0.61

Overjet

0.00

0.21

0.0

1.2

—

11.38

—

Other/unspecified enthesopathies, not elsewhere classified

249

1.13

0.20

1.4

1.3

12.57

13.09

u/l

0.07

229

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.20

0.0

1.3

—

10.50

—

Frontotemporal dementia

0.00

0.20

0.0

1.2

—

14.00

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.20

0.0

1.3

—

14.93

—

Thyrotropin deficiency

0.00

0.20

0.0

1.3

—

9.93

—

Striae atrophicae

0.00

0.20

0.0

1.2

—

11.36

—

Infliximab

0.00

0.20

0.0

1.1

—

10.43

—

Inflammatory disease of uterus

187

0.86

0.20

1.1

1.2

10.19

11.80

u/l

0.38

168

Lumbar disc prolapse

231

1772

0.96

0.20

1.3

13.35

13.93

u/l

0.22

207

1631

Personal history of malignant neoplasm

183

1.15

0.20

1.3

10.76

10.78

u/l

0.00

169

Visual disturbances and blindness

206

1982

1.04

0.20

1.2

1.3

12.42

14.31

u/l

0.69

185

1827

Other congenital malformations of the digestive system, including avohilmo

1.22

0.20

1.3

1.2

8.25

11.40

u/l

1.13

Appendectomy

196

1795

1.04

0.19

1.4

1.3

12.54

15.42

u/l

1.15

185

1657

Other/unspecified disorders of vestibular function

133

0.83

0.19

1.5

1.2

6.27

11.83

u/l

2.92

121

Spondylosis

234

1766

1.04

0.19

1.3

12.97

13.81

u/l

0.38

221

1627

Other erythematous conditions

1.22

0.19

1.1

1.2

7.91

11.83

u/l

1.95

Effects of foreign body entering through natural orifice

757

0.94

0.19

1.3

11.81

13.68

u/l

0.93

703

Other orthopaedic follow-up care

109

1.19

0.18

1.2

12.00

10.17

u/l

0.36

Haemorrhage in early pregnancy

384

1.09

0.18

1.1

1.2

16.71

16.16

u/l

0.04

352

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

159

1284

0.96

0.18

1.3

11.18

14.75

u/l

1.77

148

1181

Use of ropinirole

121

0.83

0.18

1.3

1.2

14.30

11.80

u/l

—

108

Mixed hyperlipidaemia

121

0.83

0.18

1.2

7.40

12.52

u/l

—

109

Maternal care for other known or suspected fetal problems

103

0.85

0.17

1.5

1.2

10.71

13.48

u/l

0.64

Vitamin B12 deficiency anaemia

387

1.09

0.17

1.5

1.3

8.94

12.46

u/l

1.95

354

Spasmodic torticollis

1.13

0.17

1.6

1.2

6.14

12.57

u/l

—

Glaucoma suspect

145

1508

0.96

0.17

1.3

15.16

13.74

u/l

0.18

129

1382

Other specific joint derangements/joint disorders

228

1465

0.97

0.16

1.4

1.3

21.01

13.78

u/l

0.57

208

1354

Selective serotonin reuptake inhibitors

389

2070

0.98

0.16

1.2

1.3

15.61

14.33

u/l

0.36

361

1907

Benign neoplasm: Skin of scalp and neck

1.18

0.16

1.1

1.2

14.88

10.43

u/l

—

Excessive, frequent and irregular menstruation

446

0.95

0.16

1.3

1.2

10.31

15.44

u/l

0.83

406

Oral leukoplakia, including avohilmo

1.14

0.16

1.4

1.1

17.88

12.18

u/l

—

Post-traumatic wound infection, not elsewhere classified

1.14

0.16

1.3

1.2

15.63

10.98

u/l

—

Delivery

510

0.95

0.16

1.2

9.84

15.73

u/l

1.21

461

Ovarian cyst

442

0.94

0.16

1.2

9.53

15.28

u/l

1.00

402

Mouth breathing

131

1361

0.96

0.16

1.3

13.78

15.23

u/l

0.42

120

1267

Adhesive capsulitis of shoulder

555

1.06

0.15

1.1

1.3

14.91

13.47

u/l

0.28

515

Single spontaneous delivery

510

0.95

0.15

1.2

10.53

15.73

u/l

0.99

461

Superficial injury of shoulder and upper arm

338

0.92

0.15

1.6

1.3

15.23

12.28

u/l

0.43

311

Other and unspecified erythematous conditions

1.11

0.15

1.1

1.2

8.00

12.04

u/l

—

Injury of muscle and tendon at hip and thigh level

255

1.10

0.15

1.6

1.3

10.04

12.26

u/l

0.82

236

Inflammatory diseases of prostate (prostatitis)

595

1.06

0.15

1.4

1.3

11.38

13.52

u/l

1.09

555

Other congenital malformations of the digestive system

1.20

0.14

1.3

1.2

6.80

10.66

u/l

—

Chalazion

305

0.92

0.13

1.5

1.3

12.21

12.41

u/l

0.03

281

Testicular dysfunction

0.81

0.13

1.1

1.2

22.88

11.44

u/l

—

Mood disorders, excluding more controls

336

2016

0.98

0.13

1.2

1.3

14.93

14.28

u/l

0.16

316

1865

Monoarthritis, not elsewhere classified

1.17

0.13

1.4

1.3

16.36

9.54

u/l

0.87

Hordeolum and other deep inflammation of eyelid

117

0.85

0.13

1.3

1.2

12.00

11.77

u/l

—

105

Appendicitis, broad definition

242

2222

0.98

0.13

1.4

1.3

12.32

15.19

u/l

1.51

231

2043

Maternal care for known or suspected fetal abnormality and damage

1.15

0.12

1.4

1.3

12.17

14.11

u/l

0.31

Visual disturbances

173

1777

0.97

0.12

1.3

12.72

14.40

u/l

0.49

156

1635

Striking against or struck by other objects

943

1.04

0.11

1.3

17.00

13.49

u/l

0.77

876

Other arthrosis

204

1400

0.98

0.11

1.3

20.13

13.41

u/l

0.46

189

1295

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

965

0.96

0.11

1.3

11.60

15.17

u/l

1.18

891

Coxarthrosis, primary, with hip surgery

222

2105

0.98

0.11

1.4

1.3

18.70

13.27

u/l

0.40

209

1936

Dystonia

124

1.13

0.11

1.3

8.00

12.87

u/l

1.18

110

Artrosis, including avohilmo

335

1867

0.98

0.11

1.3

14.05

13.98

u/l

0.02

311

1718

Transport accidents

137

1172

0.97

0.10

1.3

20.73

14.40

u/l

0.76

125

1091

Open wound of wrist and hand

152

1430

1.03

0.10

1.3

16.48

15.99

u/l

0.06

143

1321

Cervicalgia

678

0.96

0.10

1.3

1.2

11.72

13.13

u/l

0.49

633

Benign neoplasm: Pancreas

1.15

0.10

1.2

9.00

12.82

u/l

1.22

Other disorders of choroid

1.14

0.10

1.2

9.80

10.54

u/l

—

Sleep disorders, other/unspecified

1.14

0.10

1.0

1.1

6.80

11.92

u/l

—

Dysplasia of cervi uteri

283

0.94

0.10

1.1

1.2

8.63

17.95

u/l

1.07

257

Subjective visual disturbances

798

0.96

0.09

1.3

11.29

14.55

u/l

0.81

737

Special screening examination for other diseases and disorders

350

0.94

0.09

1.3

1.2

14.96

13.57

u/l

0.21

329

Cystitis

333

2010

0.98

0.09

1.3

18.13

13.46

u/l

0.54

315

1862

conjunctival degenerations and deposits

1.11

0.09

1.5

1.2

9.50

12.75

u/l

—

Diseases of appendix

246

2236

0.98

0.08

1.4

1.3

12.31

15.16

u/l

1.53

235

2057

Radiculopathy

626

1.04

0.08

1.2

14.53

13.73

u/l

0.15

578

Carpal tunnel syndrome

217

1914

0.98

0.08

1.3

12.07

14.52

u/l

1.41

197

1768

Spontaneous rupture of synovium and tendon

253

1.07

0.08

1.2

1.3

18.93

11.56

u/l

1.03

232

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.82

0.08

1.0

1.2

13.80

12.55

u/l

—

Viral conjunctivitis, including avohilmo

0.82

0.08

1.4

1.1

11.60

11.39

u/l

—

Haemorrhagic disorder due to circulating anticoagulants

0.79

0.08

1.0

1.3

7.00

14.12

u/l

—

Postpartum hemorraghe, parous women as controls

171

1.08

0.08

1.2

14.55

13.25

u/l

0.20

157

Fourth [trochlear] nerve palsy

1.06

0.08

1.3

1.2

9.14

11.00

u/l

—

Crossbite

0.85

0.07

1.0

1.2

16.67

12.58

u/l

—

Burn and corrosion of trunk

0.83

0.07

1.2

1.3

9.50

10.94

u/l

—

Anorexia (incl.atypical)

0.84

0.07

1.2

10.67

13.68

u/l

—

Amblyopia ex anopsia

0.80

0.07

1.5

1.2

7.00

11.75

u/l

—

Excessive vomiting in pregnancy

0.80

0.07

1.3

9.83

12.48

u/l

—

Neurotic, stress-related and somatoform disorders

281

1907

1.01

0.07

1.2

1.3

12.93

14.99

u/l

0.97

256

1756

Diabetes mellitus in pregnancy

169

0.94

0.07

1.2

15.96

12.63

u/l

0.54

157

Trochanteric bursitis

418

0.96

0.07

1.3

9.83

10.99

u/l

0.28

384

Left hemicolectomy

1.05

0.07

1.3

7.22

13.92

u/l

—

Abnormal findings on diagnostic imaging of central nervous system

1.03

0.07

1.2

9.89

10.75

u/l

—

Pediculosis, acariasis and other infestations, including avohilmo

336

0.95

0.06

1.2

1.3

18.08

12.50

u/l

0.89

313

Use of rasagiline

0.85

0.06

1.3

9.37

11.49

u/l

—

Calculus of lower urinary tract

226

1.06

0.06

1.3

15.13

13.85

u/l

0.10

207

Foreign body or object entering through skin

138

1.09

0.06

1.1

1.3

13.27

11.28

u/l

0.58

127

Coxarthrosis, primary

289

2369

1.01

0.06

1.3

17.13

13.31

u/l

0.35

271

2177

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

720

1.03

0.06

1.3

11.71

13.66

u/l

0.95

666

Primary open-angle glaucoma, strict

123

1250

0.98

0.06

1.3

15.47

13.71

u/l

0.20

115

1137

Eating disorders

109

1.10

0.06

1.1

1.2

11.00

13.00

u/l

0.33

Medical abortion

140

770

0.98

0.05

1.3

1.2

10.10

13.74

u/l

1.08

132

696

Trigger finger

404

0.97

0.05

1.6

1.2

11.41

12.58

u/l

0.23

374

Necrosis of pulp, including avohilmo

168

1681

0.99

0.04

1.3

16.73

15.19

u/l

0.31

155

1557

Depression or dysthymia

263

1421

1.01

0.04

1.3

12.70

14.47

u/l

0.67

248

1313

Unspecified dementia

552

0.97

0.04

1.3

13.30

12.14

u/l

0.18

501

Allergic rhinitis

527

0.97

0.04

1.2

1.3

12.78

12.81

u/l

0.00

490

Other obstructive and reflux uropathy

101

1.09

0.04

1.4

1.2

10.64

13.51

u/l

0.42

Complications of labour and delivery

116

654

0.98

0.04

1.2

13.60

14.41

u/l

0.12

107

601

Foreign body entering into or through eye or natural orifice

190

1.05

0.04

1.4

1.3

11.47

12.38

u/l

0.17

176

Infections of genitourinary tract in pregnancy

119

0.92

0.04

1.5

1.3

9.45

11.82

u/l

0.54

105

Excessive earwax

271

2435

1.01

0.03

1.3

11.98

14.24

u/l

1.43

251

2244

Other noninflammatory disorders of vagina

161

1.06

0.03

1.5

1.2

8.00

21.05

u/l

0.80

147

Pain in joint

205

1270

0.99

0.03

1.4

1.3

22.62

14.46

u/l

0.57

186

1182

Meniscus derangement

217

1428

1.01

0.03

1.2

1.3

11.95

13.39

u/l

1.01

202

1321

Maternal care for other conditions predominantly related to pregnancy

174

0.95

0.02

1.3

1.2

13.59

13.86

u/l

0.03

161

Herpesviral keratitis and keratoconjunctivitis

122

1.07

0.02

1.2

25.46

13.49

u/l

0.42

114

Other hammer toe(s) (acquired)

563

1.02

0.02

1.4

1.3

11.65

11.32

u/l

0.08

516

Nasal polyp

729

1.02

0.02

1.2

1.3

13.01

14.04

u/l

0.33

669

Artificial joint operation, meniscal resection

395

2513

1.00

0.02

1.3

16.22

13.79

u/l

0.29

362

2315

Other disorders of conjunctiva

529

0.98

0.02

1.4

1.3

12.31

12.60

u/l

0.04

486

Other female pelvic inflammatory diseases

312

1.03

0.02

1.2

1.3

15.89

15.86

u/l

0.00

285

Migraine with aura

438

0.98

0.01

1.3

10.59

14.59

u/l

0.62

412

Other disorders of amniotic fluid and membranes

1.07

0.01

1.3

11.00

13.15

u/l

—

Acne, including avohilmo

172

1.03

0.01

1.1

1.2

16.32

14.39

u/l

0.29

154

Lesion of sciatic nerve

177

0.96

0.01

1.1

1.3

15.82

11.14

u/l

0.67

164

Other disorders of bladder

538

0.98

0.01

1.3

18.42

12.53

u/l

0.70

496

Lichen planus, including avohilmo

578

0.99

0.01

1.3

13.06

15.12

u/l

0.29

530

Primary hyperparathyroidism

323

1.02

0.01

1.1

1.3

12.46

15.50

u/l

0.23

294

Primary open-angle glaucoma

157

1517

1.00

0.01

1.2

1.3

16.51

13.27

u/l

0.50

146

1390

Sixth [abducent] nerve palsy

114

1.05

0.00

1.2

14.75

12.75

u/l

0.21

104

Internal derangement of knee

127

1264

0.99

0.00

1.3

12.77

13.68

u/l

0.21

116

1171

Migraine without aura and triptan purchases

176

0.97

0.00

1.4

1.2

14.24

12.46

u/l

0.38

161

Pregnancy with abortive outcome

150

785

1.00

0.00

1.3

1.2

11.04

13.63

u/l

0.64

139

709

Acute appendicitis

228

2121

1.00

0.00

1.4

1.3

12.58

15.32

u/l

1.32

218

1954

Deviated nasal septum

124

1232

1.01

0.00

1.3

15.25

14.44

u/l

0.17

112

1138

Superficial injury of wrist and hand

464

1.01

0.00

1.3

20.50

13.20

u/l

0.35

430

Pregnancy hypertension

550

0.99

0.00

1.3

1.2

12.87

14.96

u/l

0.30

506

Anxiety disorders

283

1940

1.00

0.00

1.2

1.3

12.90

14.89

u/l

0.94

258

1786

Irritable bowel syndrome

703

1.00

0.00

1.3

10.14

11.59

u/l

0.55

651

Other inflammation of eyelid, including avohilmo

120

1200

1.00

0.00

1.2

1.3

14.39

14.77

u/l

0.07

112

1105

Persons encountering health services in circumstances related to reproduction

129

865

1.00

0.00

1.2

19.08

13.80

u/l

0.43

118

797

Wet age-related macular degeneration

885

1.00

0.00

1.2

1.3

11.25

14.43

u/l

0.90

799

Other peripheral vertigo

302

0.99

0.00

1.3

13.73

11.54

u/l

0.29

278

Systemic atrophies primarily affecting the central nervous system

139

1.01

0.00

1.1

1.2

8.64

13.21

u/l

0.89

126

Abnormal involuntary movements

435

1.01

0.00

1.3

13.83

13.52

u/l

0.03

399

Endometriosis diagnosis and infertility diagnosis occurring together

106

1.04

0.00

1.1

1.3

13.55

12.95

u/l

0.06

Antenatal screening

102

0.99

0.00

1.3

1.2

12.28

14.22

u/l

0.26

Hereditary corneal dystrophies

1.02

0.00

1.5

1.2

8.10

13.43

u/l

—

Nontoxic goitre/thyroid nodule

926

1.00

0.00

1.2

1.3

11.24

13.66

u/l

0.71

844

Stenosis and insufficiency of lacrimal passages

291

1.00

0.00

1.3

11.64

11.51

u/l

0.02

267

Postpartum haemorrhage

185

0.98

0.00

1.2

14.55

14.32

u/l

0.03

170

Primary coxarthrosis, bilateral

133

1331

1.00

0.00

1.4

1.3

24.30

12.92

u/l

0.52

123

1213

Postpartum hemorraghe, all women as controls

217

0.99

0.00

1.2

14.55

14.15

u/l

0.05

199

Undefined dementia

554

1.00

0.00

1.3

13.30

13.11

u/l

0.02

502

Dengue fever [classical dengue]

0.00

0.0

1.2

—

10.40

—

Relapsing fevers, including avohilmo

0.00

0.0

1.2

—

9.40

—

Nonadministration of surgical and medical care

0.00

0.0

1.3

—

10.33

—

Unspecified pneumoconiosis

0.00

0.0

1.3

—

14.71

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

17.40

—

Eccrine sweat disorders

0.00

0.0

1.1

—

8.86

—

Carcinoma in situ of lip

0.00

0.0

1.2

—

9.40

—

Carcinoma in situ, other/unspecified

0.00

0.0

1.6

—

8.80

—

Juvenile Open Angle Glaucoma

0.00

0.0

1.1

—

7.75

—

Use of pergolide

0.00

0.0

1.5

—

8.17

—

Degenerative and vascular disorders of ear

0.00

0.0

1.2

—

10.00

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.0

1.2

—

9.11

—

Chloasma

0.00

0.0

1.0

—

10.33

—

Open bite that required surgery (Lefort1 or BSSO)

0.00

0.0

1.2

—

8.20

—

Migraine, unspecified, drug-induced

0.00

0.0

1.1

—

9.43

—

Knuckle pads

0.00

0.0

1.3

—

7.33

—

Congenital deformities of feet, including avohilmo

0.94

0.00

1.0

1.2

19.20

10.96

u/l

—

Crohn disease (strict definition, all UC cases excluded)

0.99

0.00

1.2

91.89

11.45

u/l

—

Disorder of bilirubin metabolism, other/unspecified

0.00

0.0

1.0

—

9.17

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.3

—

13.63

—

Lesion of medial popliteal nerve

0.00

0.0

1.3

—

8.11

—

Neuroendocrine tumor and carcinoma of stomach

0.00

-0.00

0.0

1.1

—

11.71

—

Colour vision deficiencies

0.00

-0.00

0.0

1.2

—

17.00

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.2

—

10.40

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.3

—

14.33

—

Hypospadias

0.00

-0.00

0.0

1.3

—

10.83

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

1.4

—

14.80

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

1.4

—

15.80

—

Mastocytosis

0.00

-0.00

0.0

1.4

—

13.13

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.2

—

9.33

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

-0.00

0.0

1.2

—

13.22

—

Absence of one kidney, including avohilmo

0.00

-0.00

0.0

1.4

—

13.00

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.2

—

13.11

—

Traumatic amputation at neck level

0.00

-0.00

0.0

1.2

—

14.40

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.1

—

14.14

—

Superficial injury of ankle and foot, unspecified

0.00

-0.00

0.0

1.0

—

15.00

—

Laparoscopic left hemicolectomy

0.96

-0.00

1.2

1.3

8.60

10.37

u/l

—

Maxillary retrognathism

0.00

-0.00

0.0

1.1

—

12.78

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

-0.00

0.0

1.3

—

12.75

—

Mandibular hypoplasia

0.00

-0.00

0.0

1.1

—

9.43

—

Motor neuron disease (with DMD)

0.88

-0.00

1.2

1.3

5.50

13.00

u/l

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.5

—

6.33

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.2

—

10.33

—

Injury of heart

0.00

-0.00

0.0

1.0

—

21.60

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.2

—

10.20

—

Other specified/unspecified inflammatory spondylopathies

1.00

-0.00

1.0

1.3

9.00

11.71

u/l

—

Other specified/unspecified spondylopathies

0.91

-0.00

1.4

1.2

7.63

12.50

u/l

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.2

—

9.33

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.4

—

7.67

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.2

—

17.33

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

1.2

—

13.67

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.2

—

10.80

—

Other dermatomyositis

0.00

-0.00

0.0

1.0

—

15.29

—

Galactorrhea

0.00

-0.00

0.0

1.2

—

12.00

—

Vaginal lichen planus

0.00

-0.00

0.0

1.0

—

16.57

—

Accidental poisoning by and exposure to other gases and vapours

0.00

-0.00

0.0

1.3

—

13.44

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.0

—

8.86

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.0

—

8.71

—

Contact with blunt object, undetermined intent

0.00

-0.00

0.0

1.1

—

9.57

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.3

—

10.67

—

Progressive vascular leukoencephalopathy

180

1.00

-0.00

1.1

1.3

11.44

15.61

u/l

0.55

165

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

1.2

—

9.00

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.3

—

9.43

—

Unspecified hairloss

0.00

-0.00

0.0

1.4

—

9.00

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

7.40

—

Alopecia universalis

0.00

-0.00

0.0

1.2

—

14.83

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.1

—

12.00

—

Other and unspecified firearm discharge, undetermined intent

0.00

-0.00

0.0

1.2

—

10.40

—

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.2

—

10.40

—

Aggressive periodontitis

0.91

-0.00

1.0

1.2

9.80

11.24

u/l

—

Onychogryphosis

0.00

-0.00

0.0

1.0

—

14.60

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.2

—

14.40

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.0

—

12.50

—

Maxillary prognathism

0.00

-0.00

0.0

1.1

—

10.43

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

10.20

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.2

—

10.40

—

Abscess of tendon sheath

0.00

-0.00

0.0

1.3

—

9.00

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.2

—

16.60

—

Acute lymphocytic leukaemia, helper endpoint

0.00

-0.00

0.0

1.2

—

13.00

—

Subacute thyroiditis

0.98

-0.00

1.3

1.2

9.00

11.21

u/l

—

Brain astrocytoma, helper endpoint

0.00

-0.00

0.0

1.2

—

9.60

—

Ankylosis of teeth

0.00

-0.00

0.0

1.6

—

10.60

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

7.71

—

Yaws, including avohilmo

0.00

-0.00

0.0

1.1

—

10.29

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

9.43

—

Vertical strabismus

0.98

-0.00

1.1

1.2

20.88

11.49

u/l

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

1.0

—

9.40

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.2

—

9.33

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.0

—

9.00

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

1.0

—

9.00

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.0

—

10.00

—

Benign neoplasm: other/unspecified salivary gland

0.94

-0.00

1.4

1.2

13.38

13.53

u/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

-0.00

0.0

1.3

—

14.00

—

Trachoma

0.00

-0.00

0.0

1.2

—

10.40

—

Absence of one kidney

0.00

-0.00

0.0

1.4

—

14.80

—

Other diseases of spinal cord

1.01

-0.00

1.2

15.89

12.26

u/l

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

8.57

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

10.80

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.1

—

14.63

—

Acanthosis nigricans

0.00

-0.00

0.0

1.2

—

10.17

—

Other specified/unspecified disorders of bone/cartilage

0.91

-0.00

1.2

1.1

10.80

11.36

u/l

—

Polyp of middle ear

0.00

-0.00

0.0

1.2

—

16.60

—

Autism spe

0.00

-0.00

0.0

1.1

—

8.89

—

Benign intracranial hypertension

0.00

-0.00

0.0

1.2

—

8.00

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.2

—

9.67

—

Qualitative platelet defects

0.00

-0.00

0.0

1.0

—

7.50

—

Compression of brain

0.00

-0.00

0.0

1.0

—

9.83

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.0

—

12.20

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.2

—

9.17

—

Unspecified organic or symptomatic mental disorder

0.00

-0.00

0.0

1.3

—

8.86

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.2

—

10.40

—

Disorders in reading

0.00

-0.00

0.0

1.0

—

8.00

—

Familial chondrocalcinosis

0.00

-0.00

0.0

1.0

—

13.83

—

Other and unspecified injuries of forearm

0.00

-0.00

0.0

1.2

—

7.33

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.3

—

9.75

—

Relapsing fevers

0.00

-0.00

0.0

1.2

—

9.40

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

7.60

—

Polyneuropathy due to other toxic agents

0.00

-0.00

0.0

1.2

—

14.40

—

Disorders of puberty, all

0.00

-0.00

0.0

1.0

—

13.43

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.3

—

6.14

—

Carcinoma in situ of oral cavity and pharynx

0.00

-0.00

0.0

1.2

—

16.60

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.1

—

16.86

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

14.50

—

Toxic effect of contact with venomous animals

1.01

-0.00

1.1

1.2

17.00

11.07

u/l

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.4

—

14.80

—

Carcinoma in situ of uteri, other/unspecified

0.00

-0.00

0.0

1.0

—

15.17

—

Benign neoplasm: Penis

0.00

-0.00

0.0

1.1

—

9.50

—

Motor neuron disease ALS

0.89

-0.00

1.2

1.3

5.50

12.90

u/l

—

Sequelae of burns, corrosions and frostbite

0.00

-0.00

0.0

1.2

—

12.44

—

Childhood allergy (age < 16)

0.98

-0.00

1.0

1.3

12.20

23.64

u/l

—

Venous complications and haemorrhoids in the puerperium

0.00

-0.00

0.0

1.0

—

12.56

—

Follicular adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.1

—

10.78

—

Non-seminoma of testis

0.00

-0.00

0.0

1.2

—

14.00

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.1

—

11.29

—

Toxic encephalopathy

0.00

-0.00

0.0

1.1

—

14.00

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.2

—

9.00

—

Acute lymphocytic leukaemia, including Hilmo

0.00

-0.00

0.0

1.2

—

13.00

—

Retinoschisis and retinal cysts

0.99

-0.00

1.3

1.2

12.13

11.94

u/l

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.0

—

16.20

—

Acute lymphocytic leukaemia

0.00

-0.00

0.0

1.2

—

13.00

—

Hereditary hypogammaglobulinemia

0.00

-0.00

0.0

1.0

—

13.80

—

Trachoma, including avohilmo

0.00

-0.00

0.0

1.2

—

10.40

—

Disorders of puberty

0.00

-0.00

0.0

1.0

—

8.57

—

Dengue fever [classical dengue], including avohilmo

0.00

-0.00

0.0

1.2

—

10.40

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.4

—

15.80

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.0

—

9.43

—

Other disorders of breast and lactation associated with childbirth

0.00

-0.00

0.0

1.0

—

21.33

—

Pediculosis and phthiriasis, including avohilmo

0.00

-0.00

0.0

1.1

—

7.43

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

8.57

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.2

—

10.40

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.2

—

13.20

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

10.40

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

1.4

—

8.00

—

Explosion of other materials

0.00

-0.00

0.0

1.5

—

7.83

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

-0.00

0.0

1.0

—

8.60

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS